1460 Biomarkers
ID | Biomarker | Location | Application | Reference |
---|---|---|---|---|
1 | P53 | Colon, Rectum | Prognosis | Yamaguchi A et al. Cancer. 1992 |
2 | MYC-1 | Colon, Rectum | Prognosis | Yamaguchi A et al. Oncology. 1992 |
3 | CA242 | Colon, Rectum | Diagnosis | Nilsson O et al. Br J Cancer. 1992 |
4 | Sialosyl-Tn | Colon | Prognosis | Itzkowitz SH et al. Cancer. 1990 |
5 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Davey P et al. Eur J Surg Oncol. 1987 |
6 | Sialomucin | Colon, Rectum | Prognosis | Dawson PM et al. Int Surg. 1987 |
7 | Alkaline phosphatase (AP) | Colon, Rectum | Prognosis | Aabo K et al. Eur J Cancer Clin Oncol. 1986 |
8 | Tissue polypeptide-specific antigen (TPS) | Colon, Rectum | Diagnosis | Kornek G et al. Br J Cancer. 1995 |
9 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Miles WF et al. Br J Gen Pract. 1995 |
10 | Tumour-associated trypsin inhibitor (TATI) | Colon, Rectum | Diagnosis | Pasanen P et al. Scand J Clin Lab Invest. 1995 |
11 | Sialyl Lewis(a) antigen(SLA) | Colon, Rectum | Prognosis | Nakayama T et al. Cancer. 1995 |
12 | Urokinase-type plasminogen activator (uPA) | Colon, Rectum | Prognosis | Sato T et al. Oncology. 1995 |
13 | IGF-1 receptors (IGF-1R) | Colon, Rectum | Prognosis | Bhatavdekar JM et al. Eur J Surg Oncol. 1995 |
14 | C-erbB-2 | Colon, Rectum | Prognosis | Kay EW et al. Histopathology. 1994 |
15 | CA 19.9 | Colon, Rectum | Prognosis | Diez M et al. Anticancer Res. 1994 |
16 | E-cadherin | Colon, Rectum | Prognosis | Dorudi S et al. Br J Cancer. 1995 |
17 | Proliferating cell nuclear antigen (PCNA) | Colon, Rectum | Treatment | Willett CG et al. J Clin Oncol. 1994 |
18 | Carbohydrate antigen 19-9 (CA19-9) | Colon, Rectum | Prognosis | Ueda T et al. Surg Today. 1994 |
19 | P53 | Colon, Rectum | Prognosis | Zeng ZS et al. J Clin Oncol. 1994 |
21 | S-aspartate aminotransferase (S-ASAT) | Colon, Rectum | Prognosis | Graf W et al. Eur J Cancer. 1994 |
22 | Gp78 | Colon, Rectum | Prognosis | Nakamori S et al. Cancer. 1994 |
23 | Proliferating cell nuclear antigen (PCNA) | Colon, Rectum | Prognosis | al-Sheneber IF et al. Cancer. 1993 |
24 | Sialyl Lex antigen | Colon, Rectum | Prognosis | Nakagoe T et al. Cancer. 1993 |
25 | Prostaglandin E2 (PGE2) | Colon, Rectum | Prognosis | Oka M et al. Am J Surg. 1994 |
26 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Wang JY et al. Dis Colon Rectum. 1994 |
27 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Diagnosis | Zeng Z et al. Dis Colon Rectum. 1993 |
28 | Prolactin (PRL) | Colon, Rectum | Prognosis | Patel DD et al. Cancer. 1994 |
29 | Helix pomatia agglutinin | Colon, Rectum | Prognosis | Ikeda Y et al. Dis Colon Rectum. 1994 |
31 | P53 | Colon, Rectum | Prognosis | Yamaguchi A et al. Br J Cancer. 1993 |
32 | NCC-ST-439 (ST439) | Colon, Rectum | Diagnosis | Iemura K et al. Eur J Surg Oncol. 1993 |
33 | Urokinase-type plasminogen activator (uPA) | Colon, Rectum | Diagnosis | Huber K et al. Cancer Res. 1993 |
34 | Gastrin | Colon, Rectum | Prognosis | Kameyama M et al. Dis Colon Rectum. 1993 |
35 | Small Intestinal Mucin Antigen (SIMA) | Colon, Rectum | Diagnosis | Pinczower GD et al. Int J Cancer. 1993 |
36 | CD44v | Colon, Rectum | Diagnosis | Suh SI et al. J Korean Med Sci. 1995 |
37 | CD44v8-10 | Colon, Rectum | Prognosis | Yamaguchi A et al. J Clin Oncol. 1996 |
38 | CEA, CA242 | Colon, Rectum | Diagnosis | Carpelan-Holmström MA et al. Dis Colon Rectum. 1996 |
39 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Girard P et al. J Clin Oncol. 1996 |
40 | TAG-72 | Colon, Rectum | Diagnosis | Guadagni F et al. Anticancer Res. 1996 |
41 | CA 242, CEA | Colon, Rectum | Prognosis | Carpelan-Holmström M et al. Eur J Cancer. 1996 |
42 | P53 | Colon, Rectum | Prognosis | Belluco C et al. J Clin Oncol. 1996 |
43 | CD44 v6 | Colon, Rectum | Prognosis | Nihei Z et al. Surg Today. 1996 |
44 | Alpha 1-acid glycoprotein (AAG), CA 19-9 | Colon, Rectum | Prognosis | Yüceyar S et al. Int Surg. 1996 |
45 | DCC (deleted in colorectal cancer) | Colon, Rectum | Prognosis | Shibata D et al. N Engl J Med. 1996 |
46 | Matrix metalloproteinase-9 (MMP-9) | Colon, Rectum | Prognosis | Zeng ZS et al. J Clin Oncol. 1996 |
47 | Fecal CA II | Colon, Rectum | Diagnosis | Yokoyama S et al. Am Surg. 1997 |
48 | KRAS | Colon, Rectum | Prognosis | Lee JC et al. Anticancer Res. 1996 |
49 | CD44 | Colon | Diagnosis | Wong LS et al. Br J Surg. 1997 |
50 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Diagnosis | Tobaruela E et al. Int J Biol Markers. 1997 |
51 | Nm23-H1 | Colon, Rectum | Prognosis | Tannapfel A et al. Am J Gastroenterol. 1997 |
52 | Tenascin | Colon, Rectum | Prognosis | Kressner U et al. Br J Cancer. 1997 |
54 | CA19-9 | Colon, Rectum | Prognosis | Nakayama T et al. J Surg Oncol. 1997 |
55 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Fujisaki K et al. Am J Gastroenterol. 1998 |
56 | C-myc | Colon, Rectum | Prognosis | Kakisako K et al. Oncol Rep. 1998 |
58 | CD44 variant 6 (CD44v6) | Colon, Rectum | Prognosis | Wielenga VJ et al. Scand J Gastroenterol. 1998 |
60 | CD44 | Colon, Rectum | Prognosis | Ropponen KM et al. Scand J Gastroenterol. 1998 |
61 | KRAS | Colon, Rectum | Prognosis | Cerottini JP et al. Am J Surg. 1998 |
62 | D-dimer (DD) | Colon, Rectum | Diagnosis | Oya M et al. Surg Today. 1998 |
63 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Diagnosis | Kumar H et al. Clin Cancer Res. 1998 |
65 | Alpha-Catenin | Colon, Rectum | Prognosis | Raftopoulos I et al. J Surg Oncol. 1998 |
66 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Forones NM et al. Sao Paulo Med J. 1997 |
67 | Deleted in colorectal cancer (DCC) | Colon, Rectum | Prognosis | Reymond MA et al. Dis Colon Rectum. 1998 |
68 | CD44v8-10 | Colon, Rectum | Prognosis | Yamaguchi A et al. J Gastroenterol. 1998 |
69 | TP53, K-ras | Colon, Rectum | Prognosis | Hardingham JE et al. Gut. 1998 |
70 | HLA-DR antigen, Proliferating cell nuclear antigen labeling index (PCNA-LI) | Colon, Rectum | Prognosis | Kunihiro M et al. Oncology. 1998 |
71 | Tissue polypeptide-specific antigen (TPS) | Colon, Rectum | Prognosis | Mishaeli M et al. Anticancer Res. 1998 |
73 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Leichman CG et al. Oncology (Williston Park). 1998 |
74 | CD44v8-10, Sialyl LeX (SLX) | Colon, Rectum | Prognosis | Yamaguchi A et al. Oncology. 1998 |
75 | CD44 | Colon, Rectum | Prognosis | Bhatavdekar JM et al. Ann Surg Oncol. 1998 |
76 | C-erbB-2 | Colon, Rectum | Prognosis | Osako T et al. Oncology. 1998 |
78 | P53 | Colon, Rectum | Prognosis | Nitti D et al. Eur J Cancer. 1998 |
79 | C-reactive protein (CRP) | Colon, Rectum | Prognosis | Nozoe T et al. Am J Surg. 1998 |
80 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Chapman MA et al. Br J Cancer. 1998 |
81 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Ishigami SI et al. Br J Cancer. 1998 |
82 | Bcl-2 | Colon, Rectum | Prognosis | Ilyas M et al. Gut. 1998 |
83 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Diagnosis, Prognosis | Li Destri G et al. Surg Today. 1998 |
84 | Soluble interleukin-2 receptor (sIL-2R) | Colon, Rectum | Prognosis | Shibata M et al. Oncology. 1999 |
85 | NCC-ST-439 (ST439) | Colon, Rectum | Prognosis | Matsumoto K et al. Surg Today. 1999 |
86 | DCC gene | Colon, Rectum | Prognosis | Saito M et al. Oncology. 1999 |
87 | P27 (Kip1) | Colon, Rectum | Prognosis, Treatment | Belluco C et al. Ann Surg Oncol. 1999 |
88 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis, Treatment | Hyodo I et al. Eur J Cancer. 1998 |
90 | High mobility group I(Y) [HMGI(Y)] | Colon, Rectum | Diagnosis, Prognosis | Abe N et al. Cancer Res. 1999 |
91 | Soluble CD44 splice variants containing exon v6 (sCD44v6) | Colon, Rectum | Prognosis | Yamane N et al. Oncology. 1999 |
92 | Bax | Colon, Rectum | Prognosis | Sturm I et al. J Clin Oncol. 1999 |
93 | CA 242 | Colon, Rectum | Diagnosis | Spila A et al. Anticancer Res. 1999 |
94 | Sialyl Lewis X (SLX) | Colon, Rectum | Prognosis | Tanaka K et al. Hepatogastroenterology. 1999 |
95 | P27 (Kip1) | Colon, Rectum | Prognosis | Palmqvist R et al. J Pathol. 1999 |
96 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Carriquiry LA et al. Dis Colon Rectum. 1999 |
98 | P53 | Rectum | Treatment | Adell G et al. Radiother Oncol. 1999 |
100 | NuMA | Colon, Rectum | Diagnosis | Briggman J et al. Anticancer Res. 1999 |
101 | P21 | Colon, Rectum | Prognosis | Ropponen KM et al. Br J Cancer. 1999 |
102 | Liver fatty acid-binding protein (L-FABP) | Colon, Rectum | Prognosis | Yamazaki T et al. J Surg Oncol. 1999 |
103 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Aschele C et al. J Clin Oncol. 1999 |
105 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Treatment | Dawson LA et al. Cancer J Sci Am. 1999 |
106 | CD44v2 | Colon, Rectum | Treatment | Haruyama K et al. Anticancer Res. 1999 |
107 | P53, Bcl-2 | Rectum | Prognosis | Schwandner O et al. Eur J Cancer. 2000 |
109 | Anti-survivin antibodies | Colon, Rectum | Diagnosis | Rohayem J et al. Cancer Res. 2000 |
110 | CD44 | Colon, Rectum | Prognosis | Tachikawa D et al. Anticancer Res. 2000 |
111 | P21 | Colon, Rectum | Treatment | Qiu H et al. Dis Colon Rectum. 2000 |
112 | Metalloproteinases (MMPs) | Colon, Rectum | Prognosis | Sunami E et al. Oncologist. 2000 |
113 | CDC25B | Colon, Rectum | Prognosis, Treatment | Takemasa I et al. Cancer Res. 2000 |
114 | P53 | Colon, Rectum | Prognosis, Treatment | Bouzourene H et al. Eur J Cancer. 2000 |
115 | Telomerase | Colon, Rectum | Prognosis | Tatsumoto N et al. Clin Cancer Res. 2000 |
116 | Antigens A, B, H | Colon, Rectum | Prognosis | Nakagoe T et al. J Cancer Res Clin Oncol. 2000 |
117 | Glutathione | Colon, Rectum | Prognosis | Barranco SC et al. Dis Colon Rectum. 2000 |
118 | Insulin-like growth factor I (IGF-I) | Colon, Rectum | Diagnosis | Renehan AG et al. J Clin Endocrinol Metab. 2000 |
120 | Endothelin-1 (ET-1) | Colon, Rectum | Diagnosis | Simpson RA et al. Br J Surg. 2000 |
121 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Treatment | Chin KF et al. Br J Cancer. 2000 |
122 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Werther K et al. Eur J Surg Oncol. 2000 |
123 | Hyaluronic acid (HA) | Colon, Rectum | Prognosis | Llaneza A et al. Br J Surg. 2000 |
125 | P53 autoantibodies | Colon, Rectum | Prognosis | Takeda A et al. Eur J Surg. 2001 |
126 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Broll R et al. Eur J Surg Oncol. 2001 |
127 | Ki-67 | Colon, Rectum | Prognosis | Petrowsky H et al. Eur J Surg Oncol. 2001 |
128 | c-Myb, Bcl-x | Colon, Rectum | Prognosis | Biroccio A et al. Am J Pathol. 2001 |
130 | Bax | Colon, Rectum | Prognosis | Giatromanolaki A et al. Anticancer Res. 2001 |
132 | Carcinoembryonic gene member 2 (CGM2) | Colon, Rectum | Diagnosis | Douard R et al. Surgery. 2001 |
133 | Transforming growth factor-beta1(TGFbeta1) | Colon, Rectum | Diagnosis | Tsushima H et al. Clin Cancer Res. 2001 |
134 | Ki-67 | Colon, Rectum | Treatment | Adell G et al. Int J Radiat Oncol Biol Phys. 2001 |
135 | Angiomodulin (tumor-derived adhesion factor/mac25) | Colon, Rectum | Prognosis | Adachi Y et al. Int J Cancer. 2001 |
137 | Cytokeratin 19, 20 | Colon, Rectum | Prognosis | Fujita S et al. Int J Colorectal Dis. 2001 |
138 | Matrilysin | Colon, Rectum | Prognosis | Adachi Y et al. Int J Cancer. 2001 |
139 | Faecal calprotectin | Colon, Rectum | Diagnosis | Tibble J et al. Gut. 2001 |
140 | Metallothionein (MT) | Colon, Rectum | Prognosis | Hishikawa Y et al. Oncology. 2001 |
141 | Matrix metallproteinases (MMP)-2, -9 | Colon, Rectum | Diagnosis | Okada N et al. Biochem Biophys Res Commun. 2001 |
142 | Pyrimidine nucleoside phosphorylase (PyNPase) | Colon, Rectum | Prognosis | Osanai T et al. Jpn J Clin Oncol. 2001 |
143 | P53 antibody | Colon, Rectum | Diagnosis | Takeda A et al. Int J Clin Oncol. 2001 |
144 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Nakagoe T et al. Anticancer Res. 2001 |
145 | Beta-catenin | Colon, Rectum | Prognosis | Chung GG et al. Clin Cancer Res. 2001 |
146 | Bcl-2 | Rectum | Treatment | Scopa CD et al. Appl Immunohistochem Mol Morphol. 2001 |
147 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Prognosis | Yamauchi T et al. Dis Colon Rectum. 2002 |
148 | Tissue inhibitor of metalloproteinases-1 (TIMP-1) | Colon | Diagnosis | Holten-Andersen MN et al. Clin Cancer Res. 2002 |
150 | PGP9.5 | Colon, Rectum | Diagnosis | Yamazaki T et al. Clin Cancer Res. 2002 |
151 | Granulocyte-macrophage-colony stimulating factor (GM-CSF) | Colon, Rectum | Diagnosis | Mroczko B et al. Folia Histochem Cytobiol. 2001 |
152 | KAI1/CD82 | Colon, Rectum | Prognosis | Muneyuki T et al. Anticancer Res. 2001 |
153 | Fibronectin receptor (FnR, alpha5beta1 integrin) | Colon, Rectum | Treatment | Jayne DG et al. Eur J Surg Oncol. 2002 |
155 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Werther K et al. Br J Cancer. 2002 |
156 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis, Treatment | Edler D et al. J Clin Oncol. 2002 |
157 | Carbohydrate antigen 19-9 (CA19-9) | Colon, Rectum | Prognosis | Wang WS et al. Hepatogastroenterology. 2002 |
158 | Intercellular adhesion molecule-1 (ICAM-1) | Colon, Rectum | Prognosis | Maeda K et al. Oncol Rep. 2002 |
159 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis, Treatment | Wang WS et al. Hepatogastroenterology. 2002 |
160 | Von Willebrand factor (vWF) | Colon, Rectum | Prognosis | Damin DC et al. Int J Colorectal Dis. 2002 |
161 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Kornmann M et al. J Gastrointest Surg. 2002 |
162 | Cytokeratin 20 (CK20) | Colon, Rectum | Diagnosis | Vlems FA et al. Mol Pathol. 2002 |
163 | Transforming growth factor-beta1(TGFbeta1) | Colon, Rectum | Diagnosis | Xiong B et al. World J Gastroenterol. 2002 |
164 | Macrophagecolony stimulating factor (M-CSF) | Colon, Rectum | Diagnosis | Mroczko B et al. Clin Chem Lab Med. 2002 |
165 | Metallothionein (MT) | Colon, Rectum | Prognosis | Janssen AM et al. Clin Cancer Res. 2002 |
168 | Angiogenin (ANG) | Colon, Rectum | Prognosis | Shimoyama S et al. Anticancer Res. 2002 |
169 | Cystatin-like metastasis-associated protein (CMAP) | Colon, Rectum | Prognosis | Utsunomiya T et al. Clin Cancer Res. 2002 |
170 | Transforming growth factor-beta1(TGFbeta1) | Colon, Rectum | Prognosis | Xiong B et al. World J Gastroenterol. 2002 |
171 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Nakayama Y et al. Anticancer Res. 2002 |
173 | C-erbB | Colon, Rectum | Prognosis | Knösel T et al. Clin Exp Metastasis. 2002 |
174 | Infiltrative growth (INF) | Colon, Rectum | Prognosis | Yamaguchi J et al. World J Surg. 2002 |
175 | SMAD4 | Colon, Rectum | Treatment | Boulay JL et al. Br J Cancer. 2002 |
176 | Survivin | Colon, Rectum | Prognosis, Treatment | Rödel F et al. Strahlenther Onkol. 2002 |
177 | Peripheral benzodiazepine receptor (PBR) | Colon, Rectum | Prognosis | Maaser K et al. Clin Cancer Res. 2002 |
178 | Thymidine phosphorylase (TP) | Colon, Rectum | Prognosis | Aoki T et al. Oncol Rep. 2002 |
179 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Sugiyama Y et al. Anticancer Drugs. 2002 |
180 | Decoy receptor 3 (DcR3) | Colon, Rectum | Treatment | Mild G et al. Int J Cancer. 2002 |
181 | Calcium-binding protein S100A4 | Colon, Rectum | Prognosis | Gongoll S et al. Gastroenterology. 2002 |
182 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Prognosis | Konno H et al. Clin Exp Metastasis. 2002 |
183 | Cathepsin D (CD) | Colon, Rectum | Prognosis | Kanber Y et al. Int J Biol Markers. 2002 |
184 | Alpha-L-fucosidase (AFU) | Colon, Rectum | Prognosis | Ayude D et al. Oncology. 2003 |
185 | Epidermal growth factor receptor (EGFR) | Colon, Rectum | Treatment | Giralt J et al. Int J Radiat Oncol Biol Phys. 2002 |
186 | KRAS2 | Colon, Rectum | Diagnosis, Prognosis | Ryan BM et al. Gut. 2003 |
187 | Endothelin-1 (ET-1) | Colon, Rectum | Diagnosis | Arun C et al. Int J Biol Markers. 2002 |
188 | Soluble tetranectin (TN) | Colon, Rectum | Prognosis | Høgdall CK et al. APMIS. 2002 |
189 | KAI1 | Colon, Rectum | Prognosis | Yang JL et al. Anticancer Res. 2002 |
190 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Gonen M et al. J Clin Oncol. 2003 |
191 | SMAD7 | Colon, Rectum | Prognosis | Boulay JL et al. Int J Cancer. 2003 |
192 | Alkaline phosphatase (AP), Performance status (PS) | Colon, Rectum | Prognosis | Yuste AL et al. Clin Colorectal Cancer. 2003 |
193 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Kawakami M et al. Surgery. 2003 |
194 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Seifert JK et al. Int J Surg Investig. 2000 |
195 | Tumor necrosis factor receptor type 1 (TNFR1) | Colon, Rectum | Prognosis | Yoshimura H et al. Anticancer Res. 2003 |
196 | c-MET | Colon, Rectum | Prognosis | Takeuchi H et al. Clin Cancer Res. 2003 |
197 | Polo-like kinase 1 (PLK1) | Colon, Rectum | Prognosis | Takahashi T et al. Cancer Sci. 2003 |
198 | Methylenetetrahydrofolate reductase (MTHFR) | Colon, Rectum | Treatment | Cohen V et al. Clin Cancer Res. 2003 |
199 | CD105 | Colon, Rectum | Prognosis | Li C et al. Br J Cancer. 2003 |
200 | CD55 | Colon, Rectum | Prognosis | Durrant LG et al. Cancer Immunol Immunother. 2003 |
202 | P53 | Colon, Rectum | Prognosis | Lashner BA et al. Am J Gastroenterol. 2003 |
203 | Tumor M2 Pyruvate Kinase (Tumor M2-PK) | Colon, Rectum | Diagnosis | Hardt PD et al. Anticancer Res. 2003 |
204 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Miura M et al. Anticancer Res. 2003 |
206 | CA19-9 | Colon, Rectum | Diagnosis, Prognosis | Nakagoe T et al. Hepatogastroenterology. 2003 |
207 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis, Treatment | Lissoni P et al. Int J Biol Markers. 2003 |
208 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Diagnosis | Sawabata N et al. Ann Thorac Surg. 2003 |
209 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Diagnosis | Marchena J et al. Hepatogastroenterology. 2003 |
210 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Abe N et al. Oncol Rep. 2008 |
211 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Chin KF et al. Eur J Surg Oncol. 2003 |
212 | Thioredoxin-1 | Colon, Rectum | Prognosis | Raffel J et al. J Lab Clin Med. 2003 |
213 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Sakamoto J et al. Oncol Rep. 2003 |
214 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Higashiyama M et al. Jpn J Thorac Cardiovasc Surg. 2003 |
216 | Cyclooxygenase 2 (COX-2) | Colon, Rectum | Prognosis | Buecher B et al. Aliment Pharmacol Ther. 2003 |
217 | MMP-2, MMP-9 | Colon, Rectum | Prognosis | Tutton MG et al. Int J Cancer. 2003 |
218 | Epidermal growth factor | Colon, Rectum | Prognosis | Kopp R et al. Dis Colon Rectum. 2003 |
219 | Leptin | Colon, Rectum | Diagnosis | Stattin P et al. Oncol Rep. 2003 |
220 | CA 242, CEA | Colon, Rectum | Diagnosis, Prognosis | Kim SB et al. Int J Biol Markers. 2003 |
221 | Cyclin-dependent kinase 4 (CDK4), p16 | Colon, Rectum | Prognosis | Zhao P et al. World J Gastroenterol. 2003 |
223 | Decay-accelerating factor (DAF) | Colon, Rectum | Diagnosis | Mizuno M et al. Am J Gastroenterol. 2003 |
224 | Laminin 5 | Colon, Rectum | Diagnosis | Lenander C et al. Mol Pathol. 2003 |
225 | Beta-catenin | Colon, Rectum | Diagnosis, Prognosis | Wong SC et al. Mol Pathol. 2003 |
226 | 17beta-hydroxysteroid dehydrogenase (17HSD) | Colon, Rectum | Prognosis | Oduwole OO et al. J Steroid Biochem Mol Biol. 2003 |
227 | Tumour-associated trypsin inhibitor (TATI) | Colon, Rectum | Diagnosis | Solakidi S et al. Clin Biochem. 2004 |
228 | Tissue inhibitor of metalloproteinases-1 (TIMP-1) | Colon, Rectum | Prognosis | Holten-Andersen M et al. Eur J Cancer. 2004 |
229 | Endothelin-1 (ET-1) | Colon, Rectum | Prognosis | Elahi MM et al. Asian J Surg. 2004 |
230 | Cyclooxygenase 2 (COX-2) | Colon, Rectum | Prognosis | Knösel T et al. Dis Colon Rectum. 2004 |
231 | Dihydropyrimidine dehydroganase (DPD) | Colon, Rectum | Prognosis, Treatment | Tsuji T et al. Cancer Lett. 2004 |
232 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Werther K et al. Acta Oncol. 2003 |
233 | Beta-catenin | Colon, Rectum | Diagnosis | Wong SC et al. Clin Cancer Res. 2004 |
234 | Dihydropyrimidine dehydrogenase (DPD) | Colon, Rectum | Prognosis | Oi K et al. Anticancer Res. 2004 |
235 | P65 | Colon, Rectum | Prognosis | Balcerczak M et al. Eur J Surg Oncol. 2004 |
236 | Platelet-derived endothelial cell growth factor (PD-ECGF) | Colon, Rectum | Prognosis | Tsuji T et al. Eur J Surg Oncol. 2004 |
237 | C-peptide | Colon, Rectum | Diagnosis | Ma J et al. J Natl Cancer Inst. 2004 |
238 | Endothelin-1 (ET-1) | Colon, Rectum | Prognosis | Arun C et al. Int J Biol Markers. 2004 |
239 | PRL-3 | Colon, Rectum | Prognosis | Peng L et al. J Cancer Res Clin Oncol. 2004 |
240 | Dipeptidase 1 (DPEP1) | Colon, Rectum | Diagnosis | McIver CM et al. Cancer Lett. 2004 |
241 | The deleted in colorectal cancer (DCC) | Colon, Rectum | Prognosis | Gal R et al. Dis Colon Rectum. 2004 |
242 | Tumor M(2)-PK | Colon, Rectum | Diagnosis | Zhang B et al. World J Gastroenterol. 2004 |
243 | Soluble (s) P-selectin | Colon, Rectum | Prognosis | Ferroni P et al. Int J Cancer. 2004 |
244 | Tenascin-C (TN-C) | Colon, Rectum | Prognosis | Sis B et al. Pathol Res Pract. 2004 |
245 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Diagnosis | Celen O et al. Neoplasma. 2004 |
246 | Tissue inhibitor of metalloproteinases-1 (TIMP-1) | Colon, Rectum | Prognosis | Yukawa N et al. Anticancer Res. 2004 |
247 | Cyclooxygenase 2 (COX-2) | Colon, Rectum | Diagnosis | Kanaoka S et al. Gastroenterology. 2004 |
248 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Broll R et al. Int J Colorectal Dis. 2005 |
249 | Dihydropyrimidine dehydrogenase (DPD) | Colon, Rectum | Treatment | Tsuji T et al. Cancer Chemother Pharmacol. 2004 |
250 | Heparanase | Colon, Rectum | Prognosis | Sato T et al. J Surg Oncol. 2004 |
251 | Survivin | Colon, Rectum | Diagnosis | Chen WC et al. World J Gastroenterol. 2004 |
252 | A3 adenosine receptors | Colon | Diagnosis | Gessi S et al. Clin Cancer Res. 2004 |
253 | Cyclo-oxgenase 2 (COX-2) | Colon, Rectum | Prognosis | Zhan J et al. Chin Med J (Engl). 2004 |
254 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Marcuello E et al. Int J Cancer. 2004 |
255 | Vascular endothelial growth factor(VEGF) | Colon, Rectum | Prognosis | Tamura M et al. J Thorac Cardiovasc Surg. 2004 |
257 | Endothelial cell nitric oxide synthase (ecNOS) | Colon, Rectum | Prognosis | Mortensen K et al. Cancer Lett. 2004 |
258 | Activated leucocyte cell adhesion molecule (ALCAM) | Colon, Rectum | Prognosis | Weichert W et al. J Clin Pathol. 2004 |
260 | P27 (Kip1) | Rectum | Treatment | Moore HG et al. Ann Surg Oncol. 2004 |
262 | Fractalkine | Colon, Rectum | Prognosis | Ohta M et al. Int J Oncol. 2005 |
263 | Laminin | Colon, Rectum | Prognosis | Saito N et al. Int J Colorectal Dis. 2005 |
264 | Matrix metalloproteinase-2 (MMP-2) | Colon, Rectum | Diagnosis | Langenskiöld M et al. Int J Colorectal Dis. 2005 |
265 | Methylenetetrahydrofolate reductase (MTHFR) | Colon, Rectum | Treatment | Etienne MC et al. Pharmacogenetics. 2004 |
266 | Prolactin (PRL) | Colon, Rectum | Diagnosis | Soroush AR et al. BMC Cancer. 2004 |
267 | Matrix metalloproteinase (MMPs), Tissue inhibitors of matrix metalloproteinases (TIMPs) | Colon, Rectum | Prognosis | Curran S et al. Clin Cancer Res. 2004 |
268 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Prognosis | Soumaoro LT et al. Clin Cancer Res. 2004 |
269 | Heparanase | Colon, Rectum | Prognosis | Nobuhisa T et al. J Cancer Res Clin Oncol. 2005 |
270 | Connective tissue growth factor(CTGF) | Colon, Rectum | Prognosis | Lin BR et al. Gastroenterology. 2005 |
271 | Cathepsin H | Colon, Rectum | Prognosis | Schweiger A et al. Int J Biol Markers. 2004 |
272 | Bcl-2 | Colon, Rectum | Prognosis | Giannoulis K et al. Tech Coloproctol. 2004 |
273 | Alphavbeta6 integrin | Colon, Rectum | Prognosis | Bates RC et al. J Clin Invest. 2005 |
275 | Cysteine peptidase (CP) | Colon, Rectum | Prognosis | Szwed R et al. World J Gastroenterol. 2005 |
276 | Thymidine phosphorylase (TP) | Colon, Rectum | Prognosis | Yasuno M et al. Oncol Rep. 2005 |
277 | Particularly interesting new cysteine-histidine-rich protein (PINCH) | Colon, Rectum | Prognosis | Gao J et al. Neoplasia. 2004 |
278 | Serine threonine receptor-associated protein (STRAP) | Colon, Rectum | Treatment | Buess M et al. Neoplasia. 2004 |
279 | Mannan-binding lectin-associated serine protease 2 (MASP-2) | Colon, Rectum | Prognosis | Ytting H et al. Clin Cancer Res. 2005 |
280 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Diagnosis | Xiong B et al. World J Gastroenterol. 2005 |
282 | Thymidine phosphorylase (TP) | Colon, Rectum | Treatment | Hasegawa S et al. Oncol Rep. 2005 |
283 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Inoue T et al. J Gastroenterol. 2005 |
286 | Von Willebrand factor (vWF) | Colon, Rectum | Prognosis | Wang WS et al. World J Gastroenterol. 2005 |
287 | SMAD4 | Colon, Rectum | Prognosis | Alazzouzi H et al. Clin Cancer Res. 2005 |
288 | Epidermal growth factor receptor (EGFR) | Rectum | Prognosis, Treatment | Giralt J et al. Radiother Oncol. 2005 |
289 | Ornithine decarboxylase (ODC) | Colon, Rectum | Diagnosis, Treatment | Hu HY et al. World J Gastroenterol. 2005 |
290 | Alkaline sphingomyelinase | Colon, Rectum | Diagnosis | Di Marzio L et al. Cancer Epidemiol Biomarkers Prev. 2005 |
291 | Placenta growth factor (PlGF) | Colon, Rectum | Prognosis | Wei SC et al. Gut. 2005 |
292 | Zeste homolog 2(EZH-2) | Colon, Rectum | Prognosis | Mimori K et al. Eur J Surg Oncol. 2005 |
293 | Bax | Colon, Rectum | Treatment | Chang HJ et al. Hum Pathol. 2005 |
294 | CYP51 | Colon, Rectum | Prognosis | Kumarakulasingham M et al. Clin Cancer Res. 2005 |
295 | Matrix metalloproteinase-2, Metalloproteinase-1 | Colon, Rectum | Prognosis | Waas ET et al. Dis Colon Rectum. 2005 |
296 | Ku, p53, p21,, p16 | Colon, Rectum | Treatment | Komuro Y et al. Hepatogastroenterology. 2005 |
299 | Telomerase reverse transcriptase | Colon, Rectum | Treatment | Komuro Y et al. Hepatogastroenterology. 2005 |
300 | Ku70 | Colon, Rectum | Prognosis | Komuro Y et al. Hepatogastroenterology. 2005 |
301 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Ohrling K et al. J Clin Oncol. 2005 |
302 | Epidermal growth factor receptor (EGFR) | Colon, Rectum | Treatment | Cunningham MP et al. Int J Oncol. 2005 |
303 | Soluble urokinase plasminogen activator receptor (suPAR) | Rectum | Prognosis | Riisbro R et al. Int J Biol Markers. 2005 |
304 | Insulin-like growth factor-II(IGF-II) | Colon, Rectum | Prognosis | Zhao R et al. Cancer Epidemiol Biomarkers Prev. 2005 |
305 | Thymidine kinase (TK) | Colon, Rectum | Treatment | Topolcan O et al. Anticancer Res. 2005 |
307 | Cytokeratin 20 (CK20) | Colon, Rectum | Diagnosis | Guo J et al. J Gastroenterol Hepatol. 2005 |
308 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Bendardaf R et al. Oncol Rep. 2005 |
309 | Galectin-3 | Colon, Rectum | Prognosis | Endo K et al. Anticancer Res. 2005 |
310 | Plasminogen activator inhibitor-1 (PAI-1) | Colon, Rectum | Prognosis | Sakakibara T et al. Br J Cancer. 2005 |
311 | Thymidine phosphorylase (TP), Dihydropyrimidine dehydrogenase (DPD), Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Lassmann S et al. Int J Colorectal Dis. 2006 |
312 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Hitre E et al. Pharmacogenet Genomics. 2005 |
313 | Ki-67 | Colon, Rectum | Prognosis | Oshima CT et al. Neoplasma. 2005 |
314 | CD59 | Colon, Rectum | Prognosis | Watson NF et al. Cancer Immunol Immunother. 2006 |
315 | Nicotinamide N-methyltransferase (NNMT) | Colon, Rectum | Diagnosis | Roessler M et al. Clin Cancer Res. 2005 |
316 | CD24 | Colon, Rectum | Prognosis | Weichert W et al. Clin Cancer Res. 2005 |
318 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Treatment | Smith FM et al. Int J Radiat Oncol Biol Phys. 2006 |
319 | Vascular endothelial growth factor (VEGF) | Rectum | Treatment | Zlobec I et al. Cancer. 2005 |
320 | Excision repair cross-complementation group 1 (ERCC1) | Colon, Rectum | Prognosis | Park DJ et al. Clin Adv Hematol Oncol. 2003 |
322 | Migration inhibitory factor(MIF) | Colon | Treatment | Yao K et al. Clin Cancer Res. 2005 |
323 | Tumour matrilysin | Colon, Rectum | Diagnosis | Kurokawa S et al. Gut. 2005 |
325 | Janus kinase 3 (JAK3) | Colon, Rectum | Prognosis | Mori D et al. Pathol Res Pract. 2005 |
329 | Carcinoembryonic antigen -IgM (CEA-IgM) | Colon, Rectum | Diagnosis | Castaldi F et al. Int J Biol Markers. 2005 |
330 | Glutathione S-transferase P1 (GSTP1) | Colon, Rectum | Prognosis | Sun XF et al. World J Gastroenterol. 2005 |
331 | Cathepsin D (CD) | Colon, Rectum | Diagnosis | Sebzda T et al. J Exp Ther Oncol. 2005 |
332 | Bcl-2 | Colon, Rectum | Prognosis | Zavrides H et al. Pol J Pathol. 2005 |
333 | Bcl-2 | Colon, Rectum | Prognosis | Chatla C et al. Cancer Biomark. 2005 |
334 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Okumura K et al. Cancer Chemother Pharmacol. 2008 |
335 | Bcl-2 | Colon, Rectum | Prognosis | Tzouvala M et al. Dig Dis Sci. 2008 |
336 | SFRP2 | Colon, Rectum | Diagnosis | Oberwalder M et al. Int J Colorectal Dis. 2008 |
337 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Zafirellis K et al. J Surg Res. 2008 |
338 | KRAS | Colon, Rectum | Prognosis, Treatment | De Roock W et al. Ann Oncol. 2008 |
339 | Colon cancer-specific antigen (CCSA)-2 | Colon | Diagnosis | Walgenbach-Brunagel G et al. J Cell Biochem. 2008 |
340 | Thymidylate synthase (TS), MGMT | Colon, Rectum | Treatment | Nakajima TE et al. Eur J Cancer. 2008 |
341 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Negri FV et al. Br J Cancer. 2008 |
342 | Methyl-CpG binding domain protein 4 (MBD4) | Colon, Rectum | Prognosis | Xi Y et al. Oncol Rep. 2008 |
343 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Kim JG et al. Clin Cancer Res. 2008 |
344 | C-reactive protein (CRP) | Colon, Rectum | Prognosis | Shiu YC et al. Dis Colon Rectum. 2008 |
345 | Immunosuppressive acidic protein (IAP) | Colon, Rectum | Prognosis | Toiyama Y et al. J Surg Oncol. 2008 |
346 | Epidermal growth factor receptor (EGFR), Vascular endothelial growth factor (VEGF) | Colon, Rectum | Treatment | Zlobec I et al. Br J Cancer. 2008 |
347 | CDA, MGC20553, BANK1, BCNP1, MS4A1 | Colon, Rectum | Diagnosis | Han M et al. Clin Cancer Res. 2008 |
348 | BMP7 | Colon, Rectum | Prognosis | Motoyama K et al. Ann Surg Oncol. 2008 |
349 | Ribosomal protein L19 (RPL19) | Colon, Rectum | Prognosis | Huang CJ et al. J Cell Mol Med. 2008 |
350 | Human leukocyte antigen-DR (HLA-DR) | Colon, Rectum | Prognosis | de Bruin EC et al. Clin Cancer Res. 2008 |
351 | Orptate phosphoribosyl transferase (OPRT) | Colon, Rectum | Prognosis | Yamada H et al. Oncol Rep. 2008 |
352 | CD44 variant 6 (CD44v6) | Colon, Rectum | Treatment | Peng J et al. Cancer J. 2008 |
353 | KRAS | Colon, Rectum | Treatment | Amado RG et al. J Clin Oncol. 2008 |
354 | Epidermal growth factor receptor serum (sEGFR) | Colon, Rectum | Prognosis, Treatment | Zampino MG et al. Cancer Chemother Pharmacol. 2008 |
355 | Beta-catenin | Colon, Rectum | Prognosis | Chen S et al. Scand J Gastroenterol. 2008 |
356 | Soluble intercellular adhesion molecule-1 (sICAM-1) | Colon, Rectum | Prognosis | Toiyama Y et al. Ann Surg Oncol. 2008 |
357 | Matrix metalloproteinase-9 (MMP-9) | Colon, Rectum | Prognosis | Unsal D et al. Am J Clin Oncol. 2008 |
359 | Survivin | Colon, Rectum | Treatment | Rödel F et al. Int J Radiat Oncol Biol Phys. 2008 |
360 | Amphiregulin (AR) | Colon, Rectum | Prognosis | Yamada M et al. Clin Cancer Res. 2008 |
362 | Matrix metalloproteinase-2 (MMP-2) | Colon, Rectum | Prognosis | Oshima T et al. Oncol Rep. 2008 |
363 | macrophage migration inhibitory factor (MIF) | Colon, Rectum | Diagnosis | Lee H et al. Am J Clin Pathol. 2008 |
364 | Selenium-binding protein 1 (SBP1) | Colon, Rectum | Prognosis | Li T et al. Mol Nutr Food Res. 2008 |
366 | PTEN | Colon, Rectum | Prognosis | Colakoglu T et al. Am J Surg. 2008 |
367 | Regenerating islet-derived 1 alpha (REG1A) | Colon, Rectum | Prognosis | Astrosini C et al. Int J Cancer. 2008 |
369 | Platelet-derived growth factor BB (PDGF-BB) | Colon, Rectum | Prognosis | Nakamura Y et al. Ann Surg Oncol. 2008 |
370 | hMLH1 | Colon, Rectum | Treatment | Ide T et al. Oncol Rep. 2008 |
371 | β2microglobulin (B2M) | Colon, Rectum | Prognosis | Shrout J et al. Br J Cancer. 2008 |
372 | Mitotic centromere-associated kinesin (MCAK) | Colon, Rectum | Prognosis | Ishikawa K et al. Br J Cancer. 2008 |
374 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Li M et al. Colorectal Dis. 2009 |
376 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Díaz R et al. Int J Cancer. 2008 |
377 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Yuan SQ et al. Ai Zheng. 2008 |
379 | CK20 | Colon, Rectum | Prognosis | Lugli A et al. Mod Pathol. 2008 |
382 | Beta-catenin | Colon, Rectum | Diagnosis | Elzagheid A et al. World J Gastroenterol. 2008 |
383 | DYX1C1 | Colon, Rectum | Diagnosis | Kim YJ et al. J Cancer Res Clin Oncol. 2009 |
384 | Beta-catenin | Colon, Rectum | Prognosis | Suzuki H et al. Anticancer Res. 2008 |
385 | Formin-like 2 (FMNL2) | Colon, Rectum | Diagnosis | Zhu XL et al. Int J Colorectal Dis. 2008 |
389 | CD133 | Colon, Rectum | Prognosis | Horst D et al. Br J Cancer. 2008 |
392 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Takagawa R et al. Ann Surg Oncol. 2008 |
393 | C-reactive protein (CRP) | Colon, Rectum | Prognosis | Koike Y et al. J Surg Oncol. 2008 |
394 | RHAMM, CD8(+) TILs | Colon, Rectum | Prognosis | Zlobec I et al. Br J Cancer. 2008 |
395 | HuR | Colon, Rectum | Prognosis | Yoo PS et al. Ann Surg Oncol. 2009 |
396 | hTERT transcripts (hTERT-AT) | Colon, Rectum | Diagnosis | Terrin L et al. Clin Cancer Res. 2008 |
397 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Treatment | Min BS et al. Arch Surg. 2008 |
398 | Insulin-like growth factor-1 receptor (IGF-1R) | Colon, Rectum | Treatment | Takahari D et al. Oncology. 2009 |
399 | Leptin | Colon, Rectum | Prognosis | Paik SS et al. Ann Surg Oncol. 2009 |
401 | CEA | Colon, Rectum | Prognosis | Park JW et al. Int J Radiat Oncol Biol Phys. 2009 |
402 | CXCR4 | Colon, Rectum | Prognosis | Speetjens FM et al. Cancer Microenviron. 2009 |
403 | Cyclin D2 | Colon, Rectum | Prognosis | Sarkar R et al. Colorectal Dis. 2010 |
404 | HSP70 | Colon, Rectum | Prognosis | Kocsis J et al. Cell Stress Chaperones. 2010 |
405 | Urokinase-type plasminogen activator (uPA) | Rectum | Prognosis | Minoo P et al. Hum Pathol. 2010 |
406 | Osteopontin (OPN) | No Data | Prognosis | Likui W et al. J Gastrointest Surg. 2010 |
408 | CXCL10 | Colon, Rectum | Prognosis | Jiang Z et al. Mol Biol Rep. 2010 |
409 | IQGAP1 | No Data | Prognosis | Hayashi H et al. Int J Cancer. 2010 |
410 | High-mobility group box 1 (HMGB1) | Colon, Rectum | Prognosis | Yao X et al. J Cancer Res Clin Oncol. 2010 |
411 | Survivin | Colon, Rectum | Prognosis | Xiaoyuan C et al. Ir J Med Sci. 2010 |
412 | Transgelin-2 (TAGLN2) | Colon, Rectum | Prognosis | Zhang Y et al. Cancer Sci. 2010 |
413 | P73 | No Data | Prognosis | Toumi AA et al. Appl Immunohistochem Mol Morphol. 2010 |
414 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis, Treatment | Ahn MJ et al. Cancer Res Treat. 2005 |
415 | S100A14, S100A4 | Colon, Rectum | Prognosis | Wang HY et al. Oncol Rep. 2010 |
416 | Prominin-1 (CD133) | Colon, Rectum | Diagnosis, Treatment | Artells R et al. Eur J Cancer. 2010 |
417 | Transglutaminase 2 (TGM2) | No Data | Prognosis, Treatment | Miyoshi N et al. Ann Surg Oncol. 2010 |
419 | ATP11A | No Data | Prognosis | Miyoshi N et al. Oncol Rep. 2010 |
420 | Notch1 | Colon, Rectum | Prognosis | Chu D et al. Ann Surg Oncol. 2010 |
422 | TLR4, myeloid differentiation factor 88 (MyD88) | No Data | Prognosis | Wang EL et al. Br J Cancer. 2010 |
423 | Cellular apoptosis susceptibility (CSE1L/CAS) protein | Colon, Rectum | Prognosis | Stella Tsai CS et al. Am J Pathol. 2010 |
424 | IGF-binding protein (IGFBP)-2 | No Data | Diagnosis, Prognosis | Liou JM et al. J Clin Endocrinol Metab. 2010 |
425 | MUC12 | Colon, Rectum | Prognosis | Matsuyama T et al. Int J Cancer. 2010 |
426 | Thymidylate synthase (TS) | No Data | Prognosis | Páez D et al. J Cancer Res Clin Oncol. 2010 |
427 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Karlberg M et al. Anticancer Res. 2010 |
428 | CD95 | No Data | Prognosis | Han SL et al. Int J Colorectal Dis. 2010 |
429 | hMLH1 | Colon, Rectum | Treatment | Park IJ et al. Cancer Res Treat. 2004 |
432 | Vascular endothelial growth factor (VEGF) | No Data | Prognosis | Kwon KA et al. BMC Cancer. 2010 |
433 | Soluble urokinase plasminogen activator receptor (suPAR) | Colon, Rectum | Prognosis | Lomholt AF et al. Acta Oncol. 2010 |
435 | Stomatin-like protein 2 | Colon, Rectum | Treatment | Yeoh LC et al. World J Gastroenterol. 2010 |
436 | Prefoldin 4 (PFDN4) | No Data | Prognosis | Miyoshi N et al. Ann Surg Oncol. 2010 |
437 | Prion protein, PrP(C) | Colon, Rectum | Prognosis, Treatment | Antonacopoulou AG et al. Mol Carcinog. 2010 |
438 | P16 | Colon, Rectum | Prognosis | Karamitopoulou E et al. Cancer. 2010 |
439 | Polo-like kinase 1 (PLK1) | No Data | Treatment | Rödel F et al. Am J Pathol. 2010 |
440 | Prohibitin (PHB) | Colon, Rectum | Diagnosis | Chen D et al. Int J Oncol. 2010 |
441 | Matrix metalloproteinases (MMPs) | No Data | Prognosis | Tahara K et al. Ann Surg Oncol. 2010 |
442 | Tissue inhibitor of metalloproteinases-1 (TIMP-1) | Colon, Rectum | Prognosis | Birgisson H et al. Eur J Cancer. 2010 |
444 | Cyclin E | Colon, Rectum | Prognosis | Perea J et al. World J Gastroenterol. 2010 |
445 | Metastasis-associated in colon cancer 1 (MACC1) | No Data | Prognosis | Shirahata A et al. Anticancer Res. 2010 |
446 | S100A4 | No Data | Prognosis | Kwak JM et al. World J Gastroenterol. 2010 |
447 | S100A4 | No Data | Prognosis | Boye K et al. Eur J Cancer. 2010 |
448 | ESM-1 | No Data | Diagnosis | Ji NY et al. Cancer Sci. 2010 |
450 | Jumonji domain containing 1A (JMJD1A) | No Data | Prognosis, Treatment | Uemura M et al. Clin Cancer Res. 2010 |
451 | C4.4A | No Data | Prognosis | Konishi K et al. Cancer Sci. 2010 |
452 | Tumour-associated trypsin inhibitor (TATI) | Colon, Rectum | Prognosis | Gaber A et al. BMC Cancer. 2010 |
454 | Ankyrin repeat, SOCS box-containing 9 (ASB9) | No Data | Prognosis | Tokuoka M et al. Int J Oncol. 2010 |
455 | Matrix metalloproteinase 13 (MMP13) | No Data | Prognosis | Huang MY et al. Oncol Rep. 2010 |
457 | Phospholipid scramblase 1 (PLSCR1) | No Data | Diagnosis, Prognosis | Kuo YB et al. Mol Med. 2011 |
458 | Heat shock protein 27 (HSP27) | No Data | Prognosis | Tweedle EM et al. Gut. 2010 |
459 | Toll like receptor 4 (TLR4) | Colon, Rectum | Prognosis | Cammarota R et al. J Transl Med. 2010 |
461 | Survivin | No Data | Prognosis | Sprenger T et al. Clin Cancer Res. 2011 |
462 | PTPRG | No Data | Diagnosis | van Roon EH et al. Eur J Hum Genet. 2011 |
463 | Peroxisome proliferator-activated receptor γ (PPARG) | No Data | Prognosis | Pancione M et al. PLoS One. 2010 |
464 | NHERF1 | No Data | Diagnosis | Hayashi Y et al. Neoplasia. 2010 |
465 | Mus81 | Colon, Rectum | Prognosis | Wu F et al. Cancer Sci. 2011 |
466 | Matrix metalloproteinase-7 (MMP-7) | Colon, Rectum | Prognosis | Koskensalo S et al. Tumour Biol. 2011 |
467 | STOML2 | No Data | Diagnosis | Han CL et al. Mol Cell Proteomics. 2011 |
468 | S100A4 | Colon, Rectum | Prognosis | Huang LY et al. World J Gastroenterol. 2011 |
469 | Brachyury | No Data | Prognosis | Kilic N et al. Eur J Cancer. 2011 |
470 | NDRG2 (N-Myc downstream-regulated gene 2) | Colon, Rectum | Prognosis | Chu D et al. Mol Cancer Ther. 2011 |
472 | Second mitochondria-derived activator of caspase (Smac) | Rectum | Prognosis | Yan H et al. Med Oncol. 2012 |
474 | Bcl-Xl | Colon, Rectum | Prognosis | Jin-Song Y et al. Acta Histochem. 2011 |
475 | Forkhead box M1 (FOXM1) | Colon, Rectum | Treatment | Uddin S et al. Am J Pathol. 2011 |
476 | Thymidylate synthase (TS) | Rectum | Prognosis | Conradi LC et al. Ann Surg Oncol. 2011 |
477 | Sperm-associated antigen 9 gene (SPAG9) | No Data | Diagnosis | Kanojia D et al. Am J Pathol. 2011 |
478 | CK2α | No Data | Prognosis | Lin KY et al. PLoS One. 2011 |
485 | Matrix metalloproteinase-9 (MMP-9) | Colon, Rectum | Prognosis | Chu D et al. Ann Surg Oncol. 2012 |
486 | Growth differentiation factor 15 (GDF15) | No Data | Prognosis | Wallin U et al. Br J Cancer. 2011 |
487 | HOXB7 | No Data | Prognosis | Liao WT et al. Clin Cancer Res. 2011 |
488 | Kallikrein-related peptidase 10 (KLK10) | No Data | Prognosis | Talieri M et al. Tumour Biol. 2011 |
489 | SPG20 (spastic paraplegia-20) | No Data | Diagnosis | Lind GE et al. Oncogene. 2011 |
490 | Urokinase-type plasminogen activator (uPA), Proliferating cell nuclear antigen labeling index (PCNA-LI) | Colon, Rectum | Prognosis | Tatsuta S et al. Int J Oncol. 1997 |
491 | Rabphilin-3A-like (RPH3AL) | Colon, Rectum | Diagnosis | Chen JS et al. Clin Chim Acta. 2011 |
493 | Connective tissue growth factor (CTGF) | Colon, Rectum | Treatment | Lin BR et al. Clin Cancer Res. 2011 |
494 | ADAMTS12 | Colon, Rectum | Prognosis | Wang D et al. Dig Dis Sci. 2011 |
495 | Metastasis suppressor 1 (MTSS1) | Colon, Rectum | Prognosis | Wang D et al. J Gastrointest Surg. 2011 |
497 | Matrix metalloproteinase-21 (MMP-21) | Colon, Rectum | Prognosis | Huang Y et al. J Gastrointest Surg. 2011 |
498 | p53 | No Data | Prognosis | Dastjerdi MN et al. Acta Med Iran. 2011 |
500 | α(1, 6)fucosyltransferase | Colon, Rectum | Prognosis | Muinelo-Romay L et al. Hum Pathol. 2011 |
501 | MMP-21 | Colon, Rectum | Prognosis | Wu T et al. J Surg Oncol. 2011 |
502 | Rho GDP dissociation inhibitor 2 (RhoGDI2) | Colon, Rectum | Prognosis | Fujita A et al. Int J Clin Oncol. 2012 |
503 | Neurone glial-related cell adhesion molecule (Nr-CAM) | Colon, Rectum | Prognosis | Chan JY et al. Cancer Sci. 2011 |
504 | Claudin1 (CLDN1) | No Data | Prognosis | Nakagawa S et al. Int J Oncol. 2011 |
505 | Epidermal growth factor-like domain 7 (EGFL7) | No Data | Prognosis | Wu F et al. Anticancer Res. 2011 |
506 | Testes-specific protease 50 (TSP50) | Colon, Rectum | Prognosis | Zheng L et al. PLoS One. 2011 |
507 | Notch1 | Colon, Rectum | Prognosis | Chu D et al. Clin Cancer Res. 2011 |
509 | Bag-1 | No Data | Diagnosis, Prognosis | Sun NF et al. J Cancer Res Clin Oncol. 2011 |
510 | Eukaryotic initiation factor 5A2 (EIF5A2) | No Data | Prognosis, Treatment | Zhu W et al. Gut. 2012 |
511 | Podocalyxin-like 1 (PODXL) | Colon, Rectum | Prognosis | Larsson A et al. Br J Cancer. 2011 |
512 | CXCL16 | No Data | Prognosis | Matsushita K et al. Ann Surg Oncol. 2012 |
513 | Transketolase like gene 1 (TKTL1) | No Data | Prognosis | Schwaab J et al. BMC Cancer. 2011 |
514 | Claudin-1 (CL-1) | Rectum | Prognosis | Yoshida T et al. Anticancer Res. 2011 |
515 | Secreted Protein Acidic, Rich in Cysteine (SPARC) | Colon, Rectum | Diagnosis, Prognosis | Zhang H et al. Tumour Biol. 2011 |
517 | Cyclin E | No Data | Prognosis | Zhou YJ et al. Eur J Surg Oncol. 2011 |
518 | RNA-binding motifs 3 (RBM3) | Colon, Rectum | Prognosis | Hjelm B et al. Proteomics Clin Appl. 2011 |
519 | Rpt4 | Colon, Rectum | Prognosis | McCawley N et al. Int J Cancer. 2012 |
520 | Matrix metalloproteinase-2 (MMP-2) | Colon, Rectum | Prognosis | Dong W et al. Acta Biochim Biophys Sin (Shanghai). 2011 |
522 | Leukocyte Antigen (HLA)-E | No Data | Prognosis | Benevolo M et al. J Transl Med. 2011 |
523 | CXCL10 | No Data | Prognosis | Toiyama Y et al. Int J Oncol. 2012 |
524 | E-box-binding homeobox 2 (ZEB2) | No Data | Prognosis, Treatment | Kahlert C et al. Clin Cancer Res. 2011 |
527 | Visinin-like protein-1 (VSNL-1) | No Data | Prognosis | Akagi T et al. Int J Cancer. 2012 |
528 | Pleiotrophin (PTN) | Colon, Rectum | Prognosis, Treatment | Kong Y et al. Int J Colorectal Dis. 2012 |
530 | Glucose transporter 1 (GLUT1) | No Data | Diagnosis | Saigusa S et al. Surg Today. 2012 |
531 | Indoleamine 2, 3-dioxygenase 1 (IDO1) | No Data | Prognosis | Ferdinande L et al. Br J Cancer. 2012 |
533 | Stathmin-1 (STMN1) | Colon, Rectum | Prognosis | Tan HT et al. J Proteome Res. 2012 |
534 | CXCL5 | No Data | Prognosis | Kawamura M et al. Eur J Cancer. 2012 |
535 | Ubiquitin-like with plant homeodomain, ring finger domains 1 (UHRF1) | Colon, Rectum | Treatment | Wang F et al. Ann Surg Oncol. 2012 |
536 | Mitochondrial transcription factor A (mtTFA) | Colon, Rectum | Prognosis | Nakayama Y et al. Oncol Rep. 2012 |
538 | Kallikrein-related peptidase 6 (KLK6) | No Data | Prognosis | Petraki C et al. Pathol Res Pract. 2012 |
539 | CD73 | Colon, Rectum | Prognosis | Wu XR et al. J Surg Oncol. 2012 |
540 | E-cadherin | No Data | Prognosis | Chen X et al. Mol Biol Rep. 2012 |
542 | FOXM1 | Colon, Rectum | Prognosis | Chu XY et al. Acta Histochem. 2012 |
543 | Special AT-rich sequence-binding protein 2 (SATB2) | No Data | Prognosis | Eberhard J et al. Br J Cancer. 2012 |
545 | ORM2 | No Data | Diagnosis | Zhang X et al. PLoS One. 2012 |
546 | Reversion-inducing cysteine-rich protein with Kazal motif (RECK) | No Data | Prognosis | Stenzinger A et al. Hum Pathol. 2012 |
547 | CXCR3 | Colon, Rectum | Prognosis, Treatment | Wu Z et al. Biomed Pharmacother. 2012 |
548 | Aldehyde dehydrogenase 1 (ALDH1) | Colon, Rectum | Treatment | Hessman CJ et al. Am J Surg. 2012 |
549 | Kallikrein-related peptidase 10 (KLK10) | No Data | Prognosis | Petraki C et al. Tumour Biol. 2012 |
550 | PITX1 | Colon, Rectum | Prognosis | Knösel T et al. Int J Colorectal Dis. 2012 |
552 | B7-H3 | Colon, Rectum | Prognosis | Ingebrigtsen VA et al. Int J Cancer. 2012 |
555 | EFEMP2 | Colon, Rectum | Diagnosis | Yao L et al. J Proteome Res. 2012 |
556 | Metallothionein, p53 | Rectum | Prognosis | Arriaga JM et al. Hum Pathol. 2012 |
557 | FANCJ | No Data | Prognosis | Nakanishi R et al. Ann Surg Oncol. 2012 |
558 | RalBP1 | No Data | Prognosis, Treatment | Mollberg NM et al. Cancer Biol Ther. 2012 |
560 | S100P | Rectum | Prognosis | Wang Q et al. Oncol Rep. 2012 |
561 | Cyclooxygenase-2 (COX-2) | Colon | Prognosis | Al-Maghrabi J et al. World J Gastroenterol. 2012 |
563 | Rsf-1 (HBXAP) | Rectum | Prognosis | Lin Cy et al. J Clin Pathol. 2012 |
564 | lysosome-associated protein transmembrane-4 beta (LAPTM4B) | Colon, Rectum | Prognosis | Kang Y et al. Am J Surg. 2012 |
566 | Matrix metalloproteinase-7 (MMP-7) | No Data | Prognosis | Yang B et al. Asian Pac J Cancer Prev. 2012 |
568 | Amphiregulin (AR) | Colon, Rectum | Prognosis | Ohchi T et al. Anticancer Res. 2012 |
570 | Cyclooxygenase-2 (COX-2) | No Data | Diagnosis, Treatment | Li ZG et al. Oncol Rep. 2012 |
571 | Girdin | No Data | Prognosis | Liu C et al. Mol Biol Rep. 2012 |
572 | Kallikrein-related peptidase 6 (KLK6) | Rectum | Prognosis | Ohlsson L et al. Br J Cancer. 2012 |
575 | M2-pyruvate kinase (M2-PK) | No Data | Diagnosis | Meng W et al. World J Gastrointest Oncol. 2012 |
576 | CD133 | Colon, Rectum | Prognosis | Jao SW et al. Ann Surg Oncol. 2012 |
578 | JMJD2B | No Data | Treatment | Fu L et al. Carcinogenesis. 2012 |
580 | MSP5 | Colon, Rectum | Prognosis | Shi H et al. Med Oncol. 2012 |
581 | Extracellular matrix metalloproteinase inducer (EMMPRIN) | Colon, Rectum | Prognosis | Boye K et al. Br J Cancer. 2012 |
582 | WRAP53 | No Data | Prognosis | Zhang H et al. BMC Cancer. 2012 |
583 | Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) | Colon, Rectum | Prognosis | Lochhead P et al. Eur J Cancer. 2012 |
585 | EPAS1 | Rectum | Prognosis | Mohammed N et al. Oncol Lett. 2011 |
586 | Phosphatase, tensin homolog (PTEN) | Colon, Rectum | Prognosis | Lin MS et al. Oncol Lett. 2011 |
590 | Macrophage inflammatory protein-3 alpha (MIP-3a) | No Data | Prognosis | Iwata T et al. J Surg Oncol. 2013 |
591 | Melanoma antigen D1 (MAGED1) | Colon, Rectum | Prognosis | Zeng ZL et al. J Transl Med. 2012 |
592 | RhoE | Colon, Rectum | Prognosis | Zhou J et al. Ann Surg Oncol. 2013 |
593 | Matrix metalloproteinase-13 (MMP-13) | No Data | Prognosis | Yang B et al. Scand J Clin Lab Invest. 2012 |
594 | Ras-like nuclear protein (Ran) | No Data | Prognosis | Fan H et al. Int J Clin Oncol. 2013 |
595 | Monocarboxylate transporter 4 (MCT4) | No Data | Prognosis | Nakayama Y et al. Exp Ther MED. 2012 |
596 | Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) | Colon | Prognosis, Treatment | Kim KS et al. Clin Chim Acta. 2013 |
599 | Autophagy-related gene 5 (ATG5) | No Data | Diagnosis, Prognosis | Cho DH et al. Anticancer Res. 2012 |
600 | Cytokeratin 18 (CK18) | No Data | Prognosis | Greystoke A et al. Br J Cancer. 2012 |
603 | NUCKS1 | No Data | Prognosis, Treatment | Kikuchi A et al. Int J Cancer. 2013 |
604 | Cathepsin X (Cat X) | Colon, Rectum | Prognosis | Vizin T et al. Radiol Oncol. 2012 |
605 | Integrin-linked kinase (ILK) | Colon, Rectum | Prognosis | Li R et al. J Mol Histol. 2013 |
608 | Tumor necrosis factor receptor-associated protein 1 (TRAP1) | Colon, Rectum | Prognosis | Gao JY et al. World J Gastroenterol. 2012 |
609 | Aquaporin5 (AQP5) | No Data | Prognosis | Wang W et al. World J Surg Oncol. 2012 |
611 | Deleted in liver cancer 2 (DLC2) | Colon, Rectum | Prognosis | Gao K et al. Oncol Lett. 2012 |
613 | KRAS | Colon, Rectum | Prognosis | Nakanishi R et al. Int J Clin Oncol. 2013 |
614 | BRD7 | Colon, Rectum | Prognosis | Wu WJ et al. Eur J Clin Invest. 2013 |
615 | Matrix metalloproteinases (MMPs) | Colon, Rectum | Prognosis | Koskensalo S et al. BMC Clin Pathol. 2012 |
616 | EGFR, Her2 | Colon, Rectum | Prognosis | Lu Y et al. Cancer Biomark. 2012 |
619 | Ephrin-A1 (EFNA1) | Colon, Rectum | Prognosis | Yamamoto H et al. Int J Oncol. 2013 |
620 | Plasminogen activator ihnibitor-1 (PAI-1) | Colon, Rectum | Prognosis | Halamkova J et al. Neoplasma. 2013 |
621 | Hepatitis A virus cellular receptor 1 (HAVcR-1) | No Data | Diagnosis, Prognosis | Wang Y et al. Anticancer Res. 2013 |
623 | Paxillin (PXN) | No Data | Prognosis | Chen DL et al. Carcinogenesis. 2013 |
625 | Deleted in breast cancer 1 (DBC1) | Colon, Rectum | Prognosis | Zhang Y et al. Int J Clin Oncol. 2014 |
627 | SLIT2 | No Data | Prognosis | Chen WF et al. Int J Colorectal Dis. 2013 |
628 | Telomere-specific reverse transcriptase (hTERT) | Colon, Rectum | Prognosis | Bertorelle R et al. Br J Cancer. 2013 |
629 | AC133 | Colon, Rectum | Prognosis | Ying X et al. Med Oncol. 2013 |
630 | S-phase kinase-associated protein 2 (SKP2) | No Data | Prognosis, Treatment | Tian YF et al. Tumour Biol. 2013 |
631 | Tropomyosin receptor kinases B, C (TrkB, C) | No Data | Diagnosis, Treatment | Sasahira T et al. Hum Pathol. 2013 |
632 | TAZ | No Data | Prognosis, Treatment | Yuen HF et al. PLoS One. 2013 |
633 | Plastin-3 (PLS3) | No Data | Prognosis | Yokobori T et al. Cancer Res. 2013 |
634 | Zinc finger E-box binding homeobox 1 (ZEB1) | Colon, Rectum | Prognosis | Zhang GJ et al. Oncol Lett. 2013 |
635 | GATA-binding protein 2 (GATA2) | Colon, Rectum | Prognosis | Chen L et al. Med Oncol. 2013 |
636 | TRIM28 | Colon, Rectum | Prognosis | Fitzgerald S et al. J Gastroenterol Hepatol. 2013 |
637 | CCL18 | Colon, Rectum | Prognosis | Yuan R et al. J Surg Res. 2013 |
638 | OV-6 | No Data | Prognosis | Lin CH et al. Histopathology. 2013 |
640 | Annexin A2 (ANXA2 | Colon, Rectum | Diagnosis, Prognosis | Yang T et al. Colorectal Dis. 2013 |
641 | Kallikrein-related peptidase (KLK) | No Data | Prognosis | Alexopoulou DK et al. Clin Biochem. 2013 |
642 | BRCA1-associated protein 1 (BAP1) | Colon, Rectum | Prognosis | Tang J et al. Med Oncol. 2013 |
644 | Yes-associated protein (YAP) | No Data | Prognosis | Wang Y et al. Tumour Biol. 2013 |
645 | p53 | Colon, Rectum | Prognosis | Huh JW et al. J Am Coll Surg. 2013 |
646 | P27 (Kip1) | Colon, Rectum | Prognosis | Pucciarelli et al. Colorectal Dis. 1999 |
647 | Gankyrin | No Data | Prognosis, Treatment | Bai Z et al. Cancer Res. 2013 |
649 | Calcium activated chloride channel A1 (CLCA1) | No Data | Prognosis | Yang B et al. PLoS One. 2013 |
650 | PLAC1/CP1 | No Data | Prognosis | Liu F et al. J Gastroenterol. 2014 |
651 | Spleen tyrosine kinase (Syk) | Colon, Rectum | Prognosis | Yang Z et al. Med Oncol. 2013 |
653 | Twist2 | Colon, Rectum | Prognosis | Yu H et al. World J Gastroenterol. 2013 |
654 | Cryptochrome 1 (Cry1) | Colon, Rectum | Prognosis, Treatment | Yu H et al. PLoS One. 2013 |
657 | Carbonic anhydrase II (CA II) | No Data | Diagnosis | Zhou R et al. Int J Oncol. 2013 |
659 | STAT3 | No Data | Prognosis | Gordziel C et al. Br J Cancer. 2013 |
660 | Four-and-a-half LIM domains protein 2 (FHL2) | No Data | Prognosis | Verset L et al. Br J Cancer. 2013 |
661 | Cell division cycle 20 homolog (CDC20) | Colon, Rectum | Prognosis | Wu WJ et al. J Transl Med. 2013 |
666 | MUC20 | Colon, Rectum | Prognosis | Xiao X et al. J Transl Med. 2013 |
667 | Soluble a-proliferation-inducing ligand (sAPRIL) | No Data | Diagnosis | Ding W et al. Clin Biochem. 2013 |
668 | Toll like receptor 4 (TLR4) | Rectum | Prognosis | Eiró N et al. J Immunother. 2013 |
669 | G-protein-coupled receptor 48 (GPR48) | Colon, Rectum | Prognosis, Treatment | Wu J et al. Carcinogenesis. 2013 |
670 | Paired related homoeobox 1 (PRRX1) | No Data | Prognosis | Takahashi Y et al. Br J Cancer. 2013 |
671 | Thymidylate synthase (TYMS) | Colon, Rectum | Prognosis | Lu Y et al. Clin Biochem. 2013 |
672 | Podocalyxin-like 1 (PODXL) | No Data | Prognosis, Treatment | Larsson AH et al. Diagn Pathol. 2013 |
674 | S100A10 | Colon, Rectum | Prognosis, Treatment | Shang J et al. Tumour Biol. 2013 |
675 | C-reactive protein (CRP) | No Data | Prognosis | Toiyama Y et al. Oncol Lett. 2013 |
676 | G-protein-coupled receptor 120 (GPR120) | No Data | Treatment | Wu Q et al. Oncogene. 2013 |
679 | Secreted protein acidic, rich in cysteine (SPARC) | No Data | Prognosis | Kim JY et al. Ann Coloproctol. 2013 |
680 | N-myc downregulated gene 1 (NDRG1) | Colon, Rectum | Prognosis | Mao Z et al. PLoS One. 2013 |
682 | Kininogen-1 | No Data | Diagnosis | Wang J et al. PLoS One. 2013 |
684 | Claudin-1 | Colon, Rectum | Prognosis | Shibutani M et al. Anticancer Res. 2013 |
685 | DEK | Colon, Rectum | Prognosis | Lin L et al. BMC Cancer. 2013 |
686 | Visfatin | No Data | Diagnosis | Chen M et al. Asia Pac J Clin Oncol. 2016 |
687 | Hv1 | Colon, Rectum | Diagnosis, Prognosis, Treatment | Wang Y et al. PLoS One. 2013 |
688 | T-box2 (TBX2) | No Data | Prognosis, Treatment | Han Y et al. Med Oncol. 2013 |
691 | Protein tyrosine phosphatase 1B (PTP1B) | Colon, Rectum | Prognosis | Chen Q et al. J Mol Histol. 2014 |
693 | Maspin | Rectum | Prognosis | Snoeren N et al. Br J Cancer. 2013 |
700 | HS1-associated protein X-1 (HAX-1) | Colon, Rectum | Prognosis, Treatment | Wei XJ et al. Tumour Biol. 2014 |
702 | Transmembrane protease/serine 4 (TMPRSS4) | Colon | Prognosis | Huang A et al. Med Oncol. 2013 |
703 | Inhibin β A (INHBA) | No Data | Prognosis | Okano M et al. Oncol Rep. 2013 |
707 | Aurora kinase A (AURKA) | Colon, Rectum | Prognosis | Goos JA et al. Br J Cancer. 2013 |
709 | Serpin B5 | Colon, Rectum | Prognosis | Baek JY et al. Int J Cancer. 2014 |
710 | Topoisomerase-1 (TOPO1) | No Data | Prognosis | Negri FV et al. Anticancer Res. 2013 |
713 | DVL1 | No Data | Diagnosis, Prognosis | Huang MY et al. Int J Mol Sci. 2013 |
714 | Anaplastic lymphoma kinase (ALK) | No Data | Prognosis | Bavi P et al. Br J Cancer. 2013 |
715 | Fibroblast growth factor receptor 1 (FGFR1) | Colon, Rectum | Treatment | Göke F et al. Digestion. 2013 |
716 | The dipeptidyl peptidase IV (DPPIV) | No Data | Prognosis | Park HS et al. Yonsei Med J. 2013 |
717 | Dachshund homolog 1 (DACH1) | No Data | Diagnosis, Prognosis | Yan W et al. Epigenetics. 2013 |
721 | TP53 | No Data | Prognosis | Singamsetty GK et al. Tumour Biol. 2014 |
722 | Lemur tyrosine kinase-3 (LMTK3) | Colon, Rectum | Prognosis | Shi H et al. Med Oncol. 2013 |
723 | Bax-interacting factor-1 (Bif-1) | Colon, Rectum | Prognosis | Ko YH et al. Biomed Res Int. 2013 |
724 | Epidermal growth factor receptor (EGFR) | Colon, Rectum | Prognosis | Koskensalo S et al. PLoS One. 2013 |
725 | Plastin-3 (PLS3) | No Data | Prognosis | Sugimachi K et al. Ann Surg Oncol. 2014 |
726 | C-reactive protein (CRP) | Rectum | Prognosis | Toiyama Y et al. Anticancer Res. 2013 |
727 | Cadherin 12 (CDH12) | Colon, Rectum | Diagnosis, Prognosis, Treatment | Zhao J et al. J Transl Med. 2013 |
729 | C-reactive protein (CRP) | No Data | Prognosis | Lin M et al. Exp Ther Med. 2013 |
730 | KRAS | No Data | Prognosis | Spindler KG et al. Br J Cancer. 2013 |
731 | Bmal1 | No Data | Prognosis, Treatment | Zeng ZL et al. Clin Cancer Res. 2014 |
735 | Matrilysin-2 (MMP-26) | No Data | Prognosis | Hu Q et al. Tumour Biol. 2014 |
736 | Carbonic anhydrase IX (CA9) | Rectum | Prognosis | Schweiger T et al. Eur J Cardiothorac Surg. 2014 |
738 | BIRC5 (Survivin) | Colon, Rectum | Diagnosis, Prognosis | Wang H et al. J Surg Oncol. 2014 |
739 | AT-rich interactive domain 3A (ARID3A) | Colon, Rectum | Prognosis | Song M et al. Ann Surg Oncol. 2014 |
740 | Vasohibin-1 | No Data | Prognosis | Yan Y et al. Med Oncol. 2014 |
742 | S100P | No Data | Prognosis, Treatment | Dong L et al. Mol Cell Biochem. 2014 |
743 | CXCR4 | No Data | Prognosis | Gao Y et al. Tumour Biol. 2014 |
747 | The overexpressed in lung cancer-1 (OLC1) | Colon, Rectum | Prognosis | Liu J et al. Anticancer Res. 2014 |
748 | Golgi phosphoprotein 3 (GOLPH3) | Colon, Rectum | Prognosis | Wang Z et al. J Transl Med. 2014 |
749 | hMOF | No Data | Diagnosis | Cao L et al. Int J Oncol. 2014 |
750 | YKL-40 | Colon, Rectum | Prognosis | Tarpgaard LS et al. PLoS One. 2014 |
751 | Carcinoembryonic antigen (CEA) | No Data | Prognosis | Hotta T et al. Surg Today. 2014 |
753 | Carcinoembryonic antigen (CEA) | Rectum | Prognosis | Huang CS et al. Am J Surg. 2014 |
755 | Thymine DNA glycosylase (TDG) | No Data | Treatment | Xu X et al. J Biol Chem. 2014 |
756 | HLA class II antigen | No Data | Prognosis | Sconocchia G et al. Neoplasia. 2014 |
757 | Secretoglobin, family 2A, member 1 (SCGB2A1) | No Data | Prognosis | Munakata K et al. Int J Oncol. 2014 |
759 | Cysteine-rich angiogenic inducer 61 (CYR61) | No Data | Prognosis | Jeong D et al. BMC Cancer. 2014 |
763 | Lipocalin-2 (Lcn-2) | No Data | Prognosis | Maier HT et al. World J Surg. 2014 |
765 | Lemur tyrosine kinase-3 (LMTK3) | Colon, Rectum | Prognosis | Shi H et al. Int J Clin Exp Pathol. 2014 |
768 | Nucleolin | No Data | Treatment | Wu DM et al. FEBS Lett. 2014 |
769 | Notch3 | Colon, Rectum | Prognosis | Ozawa T et al. Ann Surg Oncol. 2014 |
772 | Protocadherin 10 (PCDH10) | Colon | Prognosis | Jao TM et al. Int J Cancer. 2014 |
775 | Sirt7 | No Data | Prognosis | Yu H et al. Clin Cancer Res. 2014 |
780 | C-reactive protein (CRP) | No Data | Prognosis | Shibutani M et al. Surg Today. 2015 |
782 | RAC1b | No Data | Prognosis | Alonso-Espinaco V et al. Eur J Cancer. 2014 |
783 | LMO1 | No Data | Treatment | Liu J et al. Tumour Biol. 2014 |
785 | Tafazzin (TAZ) | Rectum | Prognosis | Pathak S et al. PLoS One. 2014 |
786 | CD133 | No Data | Prognosis | Pitule P et al. Biomed Res Int. 2014 |
787 | CD26 | No Data | Prognosis | Lam CS et al. PLoS One. 2014 |
789 | Urokinase-type plasminogen activator receptor (uPAR) | No Data | Prognosis | Illemann M et al. Cancer Med. 2014 |
790 | AMP-activated protein kinase (AMPK) | Colon, Rectum | Prognosis | Zulato E et al. Br J Cancer. 2014 |
794 | Vascular endothelial growth factor 1/Fms-like tyrosine kinase 1 (VEGFR1/Flt-1) | Colon, Rectum | Prognosis | Al-Maghrabi J et al. Tumour Biol. 2014 |
795 | IL-12p40, IL-23 | Colon, Rectum | Prognosis | Stanilov N et al. APMIS. 2014 |
796 | Ephrin type-B receptor 6 (EphB6) | Colon, Rectum | Prognosis | Peng L et al. J Mol Histol. 2014 |
800 | Calcium/calmodulin-dependent serine protein kinase (CASK) | No Data | Prognosis | Wei JL et al. Tumour Biol. 2014 |
802 | Matrix metalloproteinase-7 (MMP-7) | Colon, Rectum | Diagnosis | Keles D et al. Clin Biochem. 2014 |
806 | RAGE | No Data | Prognosis | Dahlmann M et al. Oncotarget. 2014 |
807 | NEDD9 | Colon, Rectum | Prognosis, Treatment | Li P et al. Int J Clin Exp Pathol. 2014 |
808 | DEPTOR | Colon, Rectum | Prognosis, Treatment | Lai EY et al. Asian Pac J Cancer Prev. 2014 |
809 | Glutathione S-transferase π-1 (GSTP-1) | No Data | Treatment | Zhang R et al. Int J Oncol. 2014 |
810 | Special AT-rich sequence-binding protein-1 (SATB1) | Rectum | Prognosis, Treatment | Zhang Y et al. PLoS One. 2014 |
811 | NLK | Colon, Rectum | Diagnosis, Treatment | Han Y et al. Biomed Pharmacother. 2014 |
812 | sphingosine-1-phosphate receptor 1 (S1PR1) | Colon, Rectum | Prognosis | Lin Q et al. Tumour Biol. 2014 |
814 | NAT10 (N-acetyltransferase 10) | No Data | Prognosis, Treatment | Zhang H et al. Clin Cancer Res. 2014 |
816 | ATG4B | No Data | Treatment | Liu PF et al. Autophagy. 2014 |
817 | YKL-40 | Colon, Rectum | Prognosis | Liu X et al. Med Oncol. 2014 |
818 | Podocalyxin | Colon, Rectum | Prognosis | Kaprio T et al. BMC Cancer. 2014 |
819 | Protein phosphatase, Mg2+/Mn2+ dependent, 1D (PPM1D) | Colon, Rectum | Prognosis, Treatment | Peng TS et al. Exp Ther Med. 2014 |
823 | Carcinoembryonic antigen (CEA), Serum amyloid A (SAA) | Rectum | Prognosis | Giessen C et al. Tumour Biol. 2014 |
824 | Zinc-finger protein X-linked (ZFX) | Colon, Rectum | Prognosis | Yan X et al. Int J Clin Exp Pathol. 2014 |
828 | DNAJB6 | No Data | Prognosis | Zhang TT et al. Mol Carcinog. 2015 |
831 | Thomsen-Friedenreich (TF) antigen | No Data | Diagnosis | Sakuma S et al. Int J Cancer. 2015 |
832 | Bmi1 | No Data | Prognosis | Pun JC et al. Mol Clin Oncol. 2014 |
833 | Phosphorylated p38 (p-p38) | Colon, Rectum | Prognosis | Fan XJ et al. Tumour Biol. 2014 |
835 | Lysine-specific demethylase 1 (LSD1) | No Data | Treatment | Hsu HC et al. J Cancer Res Clin Oncol. 2015 |
836 | Krüppel-like factor 4 (KLF4) | Colon, Rectum | Prognosis | Lee HY et al. World J Surg Oncol. 2014 |
837 | Stathmin-1 (STMN1) | No Data | Treatment | Wu W et al. Mol Cancer Res. 2014 |
838 | FOXC2 | No Data | Prognosis | Cui YM et al. Cancer Lett. 2014 |
840 | Phosphorylated focal adhesion kinase (P-FAK) | Colon, Rectum | Prognosis | Albasri A et al. Anticancer Res. 2014 |
841 | Vimentin methylation | Colon, Rectum | Diagnosis | Shirahata A et al. Anticancer Res. 2014 |
843 | A disintegrin, metalloprotease 8 (ADAM8) | Colon, Rectum | Treatment | Yang Z et al. BMC Cancer. 2014 |
844 | CDC42 | No Data | Prognosis | Sakamori R et al. Cancer Res. 2014 |
845 | Melanoma-associated antigen D4 (MAGE-D4) | Colon | Prognosis | Zhang QM et al. Int J Clin Exp Pathol. 2014 |
846 | IGFBP3 methylation | Colon, Rectum | Diagnosis, Prognosis | Perez-Carbonell L et al. PLoS One. 2014 |
847 | Beclin-1 | No Data | Prognosis | Yang Z et al. Clin Res Hepatol Gastroenterol. 2015 |
848 | ArhGAP30 | No Data | Prognosis | Wang J et al. Nat Commun. 2014 |
855 | Prothymosin-α (PTMA) | Colon | Prognosis | Zhang M et al. Int J Clin Exp Pathol. 2014 |
856 | Ribosomal s6 kinase4 (RSK4) | Colon | Prognosis | Cai J et al. Int J Clin Exp Pathol. 2014 |
857 | Uroplakin Ia(UPK la) | Colon | Prognosis | He Y et al. Int J Clin Exp Pathol. 2014 |
859 | Polycomb-group (PcG) | Colon, Rectum | Prognosis | Benard A et al. PLoS One. 2014 |
862 | Annexin A9 (ANXA9) | Colon | Prognosis | Miyoshi N et al. Oncol Lett. 2014 |
863 | β-catenin | Colon, Rectum | Prognosis | Gao ZH et al. Oncol Lett. 2014 |
864 | Metastasis-associated in colon cancer-1 (MACC1) | Colon | Prognosis | Yamamoto H et al. Oncol Lett. 2014 |
865 | Regenerating islet-derived gene4 (REG4) | Colon, Rectum | Prognosis | Kaprio T et al. PLoS One. 2014 |
868 | Ku70, ataxia-telangiectasia mutated (ATM) | Colon | Prognosis | Lu Y et al. Onco Targets Ther. 2014 |
869 | Structural maintenance of chromosomes 4 (SMC-4) | Colon | Treatment | Feng XD et al. Asian Pac J Cancer Prev. 2014 |
871 | SH2-containing inositol 5'-phosphatase 2 (SHIP2) | Colon, Rectum | Prognosis | Yang J et al. Dis Markers. 2014 |
874 | Rab27b | Colon, Rectum | Prognosis | Bao J et al. Gastroenterol Res Pract. 2014 |
876 | Cryptochrome 2 (CRY2) | No Data | Prognosis, Treatment | Fang L et al. Mol Cancer Ther. 2015 |
879 | Serine protease inhibitor Kazal-type 1 (SPINK1) | Colon, Rectum | Prognosis | Hu L et al. BMC Cancer. 2015 |
880 | Fibulin-1 | Colon, Rectum | Prognosis | Zhu J et al. Am J Transl Res. 2015 |
883 | Cancerous inhibitor of protein phosphatase 2A (CIP2A) | Colon, Rectum | Prognosis | Chen KF et al. BMC Cancer. 2015 |
885 | Serine protease inhibitor Kazal-type 1 (SPINK1) | Colon, Rectum | Prognosis | Chen YT et al. Pathol Oncol Res. 2015 |
886 | RAD54B | Colon, Rectum | Prognosis | Nagai Y et al. Oncotarget. 2015 |
891 | Kinesin superfamily protein 2A (KIF2A) | Colon, Rectum | Prognosis | Fan X et al. Tumour Biol. 2015 |
892 | Rab27A | Colon, Rectum | Prognosis | Shi C et al. Diagn Pathol. 2015 |
893 | Carbonic anhydrase IV (CA4) | Colon, Rectum | Prognosis | Zhang J et al. Gut. 2016 |
897 | MYBL2 | Colon, Rectum | Prognosis | Ren F et al. Am J Cancer Res. 2015 |
899 | CXCL1 | No Data | Prognosis | Ie Rolle AF et al. J Transl Med. 2015 |
900 | CD133(+)/ESA(+) cells in MVB | No Data | Prognosis | Tseng JY et al. J Surg Res. 2015 |
902 | NK2R rs4644560 GC polymorphism | Colon, Rectum | Prognosis | Fang W et al. Oncol Lett. 2015 |
904 | RPS24 | No Data | Diagnosis, Treatment | Wang Y et al. Gene. 2015 |
905 | Lactate dehydrogenase (LDH) | Colon, Rectum | Prognosis | Passardi A et al. PLoS One. 2015 |
907 | Dehydrogenase/reductase (SDR family) member 9 (DHRS9) | No Data | Prognosis | Hu L et al. Tumour Biol. 2016 |
908 | Interferon-induced transmembrane protein 1 (IFITM1) | Colon, Rectum | Prognosis, Treatment | Yu F et al. Cancer Lett. 2015 |
909 | 53BP1 | Colon | Prognosis | Bi J et al. Int J Clin Exp Pathol. 2015 |
910 | MTA2 | No Data | Prognosis, Treatment | Ding W et al. Int J Clin Exp Pathol. 2015 |
911 | Twist-related protein 1 (TWIST1) | Colon, Rectum | Prognosis, Treatment | Zhu DJ et al. Am J Cancer Res. 2015 |
917 | SDF-1 | No Data | Prognosis | Amara S et al. Cancer Biomark. 2015 |
918 | CXCR4 | No Data | Prognosis | Amara S et al. Cancer Biomark. 2015 |
919 | Neuron navigator 2 (NAV2) | Colon, Rectum | Prognosis, Treatment | Tan F et al. J Exp Clin Cancer Res. 2015 |
923 | G9a | Colon, Rectum | Treatment | Luo CW et al. Radiother Oncol. 2017 |
924 | SHP-1 | Colon, Rectum | Prognosis, Treatment | Fan LC et al. Neoplasia. 2015 |
925 | Hexokinase 1 (HK1) | No Data | Prognosis | He X et al. Tumour Biol. 2016 |
926 | Bone marrow stromal antigen 2 (BST2) | No Data | Prognosis | Chiang SF et al. Dis Markers. 2015 |
927 | Growth differentiation factor 15 (GDF15) | Colon, Rectum | Prognosis | Li C et al. Oncotarget. 2016 |
928 | Rac GTPase activating protein 1 (RACGAP1) | No Data | Prognosis | Yeh CM et al. Hum Pathol. 2016 |
930 | Stromal interaction molecule 1 (STIM1) | Colon, Rectum | Treatment | Wong HS et al. Oncotarget. 2015 |
931 | NEAT1 | No Data | Diagnosis, Prognosis | Wu Y et al. Mol Cancer. 2015 |
933 | VE1 antibody | Colon | Prognosis | Hang JF et al. Histopathology. 2016 |
937 | Amphiregulin (AR) | No Data | Diagnosis | Chen H E et al. J Clin Epidemiol. 2016 |
938 | KCTD12 | Colon, Rectum | Prognosis, Treatment | Li L et al. Sci Rep. 2016 |
940 | Olfactory receptor family 7 subfamily C member 1 (OR7C1) | Colon | Prognosis | Morita R et al. Clin Cancer Res. 2016 |
944 | CXCR3 | Colon, Rectum | Prognosis | Bai M et al. Mol Clin Oncol. 2016 |
945 | 17β-Hydroxysteroid dehydrogenase type 10 (HSD10) | No Data | Prognosis | Amberger A et al. Cancer Lett. 2016 |
946 | Interferon-induced transmembrane protein 1 (IFITM1) | Colon, Rectum | Prognosis | He J et al. Int J Clin Exp Pathol. 2015 |
949 | Excision repair cross-complementation group 1 (ERCC1) | No Data | Prognosis | Li MX et al. Chin Med J (Engl). 2016 |
950 | Zinc-finger protein X-linked (ZFX) | Colon, Rectum | Prognosis, Treatment | Yan X et al. Oncotarget. 2016 |
960 | Human homolog of Drosophila prune protein (h-prune; HGNC13420) | Colon, Rectum | Prognosis | Hashimoto M et al. Int J Cancer. 2016 |
961 | h-Prune | Colon, Rectum | Prognosis | Hashimoto M et al. Int J Cancer. 2016 |
962 | Myosin VI (MYO6) | No Data | Treatment | You W et al. Acta Biochim Biophys Sin (Shanghai). 2016 |
963 | Rab3D | Colon, Rectum | Prognosis | Luo Y et al. Int J Biochem Cell Biol. 2016 |
964 | Fatty acid-binding proteins 5 (FABP5) | No Data | Prognosis, Treatment | Kawaguchi K et al. FEBS Open Bio. 2016 |
965 | A-kinase anchor protein (AKAP4) | No Data | Diagnosis | Jagadish N et al. Oncoimmunology. 2016 |
966 | Anillin (ANLN) | Colon, Rectum | Prognosis | Wang G et al. Cancer Biomark. 2016 |
967 | Glutathione S-transferase alpha 4 (GSTA4) | No Data | Diagnosis | Yang Y et al. Oncogene. 2016 |
970 | combination of CELA1, CTRL | Colon | Diagnosis | Xie Y et al. Oncotarget. 2016 |
971 | Combination of CELA1, CTRL | No Data | Diagnosis | Xie Y et al. Oncotarget. 2016 |
972 | STEAP1 (six transmembrane epithelial antigen of the prostate 1) | No Data | Prognosis | Lee CH et al. Int J Mol Sci. 2016 |
974 | Serine protease inhibitor Kazal-type 1 (SPINK1) | Colon, Rectum | Prognosis, Treatment | Chen YT et al. J Clin Pathol. 2016 |
975 | Pinin (PNN) | No Data | Prognosis | Wei Z et al. Oncotarget. 2016 |
977 | Cytokeratin 20 (CK20) | Colon, Rectum | Prognosis | Kust D et al. Acta Clin Belg. 2016 |
980 | NDUFA4L2 | Colon, Rectum | Prognosis | Lv Y et al. ANZ J Surg. 2016 |
981 | Transforming acidic coiled-coil protein-3 (TACC3) | Colon, Rectum | Prognosis | Du Y et al. Oncotarget. 2016 |
982 | PDGFR-β | No Data | Prognosis | Mezheyeuski A et al. Oncotarget. 2016 |
983 | PDGFR-α | No Data | Prognosis | Mezheyeuski A et al. Oncotarget. 2016 |
986 | S100A4 | Colon, Rectum | Prognosis | Boye K et al. Cancer Med. 2016 |
987 | HOTAIRM1 | Colon, Rectum | Diagnosis | Wan L et al. J Cell Mol Med. 2016 |
988 | Y-Box-binding protein-1 (YB-1) | No Data | Prognosis | Shiraiwa S et al. Anticancer Res. 2016 |
989 | Combination of CCR4, TNF-α | Colon, Rectum | Prognosis | Ou B et al. Oncotarget. 2016 |
990 | Metalloproteases meprin-ɑ (MEP1A) | Colon, Rectum | Prognosis | Wang X et al. BMC Cancer. 2016 |
991 | Carbon atomsC10 | No Data | Diagnosis | Crotti S et al. Anal Bioanal Chem. 2016 |
992 | Polo-like kinase 2 (Plk2) | No Data | Prognosis | Ou B et al. Cancer Lett. 2016 |
995 | Syndecan-1 (CD138) | Colon, Rectum | Prognosis | Jary M et al. Int J Cancer. 2016 |
996 | Nucleolar protein 66 (NO66) | Colon, Rectum | Prognosis | Nishizawa Y et al. Ann Surg Oncol. 2017 |
997 | Nucleolar protein 66 (NO66 [C14orf169/MAPJD]) | Colon, Rectum | Prognosis | Nishizawa Y et al. Ann Surg Oncol. 2017 |
1000 | Chemokine (C-C motif) ligand 15 (CCL15) | Colon, Rectum | Prognosis | Yamamoto T et al. Clin Cancer Res. 2017 |
1001 | CCL15-CCR1 | Colon, Rectum | Prognosis | Yamamoto T et al. Clin Cancer Res. 2017 |
1004 | Dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2) | Colon, Rectum | Prognosis | Yan H et al. PLoS One. 2016 |
1005 | SA1 | Colon | Diagnosis | Wali RK et al. Cancer Prev Res (Phila). 2016 |
1006 | Olfactomedin 1 (OLFM1) | Colon | Prognosis | Shi W et al. J Pathol. 2016 |
1008 | CD51 | Colon | Treatment | Wang J et al. Oncogene. 2017 |
1014 | C-reactive protein (CRP) | Colon, Rectum | Prognosis | Køstner AH et al. J Surg Oncol. 2016 |
1019 | C-reactive protein (CRP) | Colon, Rectum | Prognosis | Thomsen M et al. Oncotarget. 2016 |
1020 | Cysteine-rich angiogenic inducer 61 (CYR61) | Colon, Rectum | Diagnosis | Song YF et al. Clin Transl Oncol. 2017 |
1021 | Cysteine-rich angiogenic inducer 61 (CYR61) | Colon, Rectum | Diagnosis | Song YF et al. Clin Transl Oncol. 2017 |
1022 | Thymosin β4 | Colon | Prognosis | Lee SY et al. J Pathol Transl Med. 2017 |
1023 | Thymosin β4 | Colon, Rectum | Prognosis | Lee SY et al. J Pathol Transl Med. 2017 |
1024 | Anti-FIRs (PUF60) | Colon | Diagnosis | Kobayashi S et al. Oncotarget. 2016 |
1025 | Trefoil factor 3 | No Data | Diagnosis | Li Q et al. Technol Cancer Res Treat. 2016 |
1028 | Cytoplasmic polyadenylation element-binding protein 4 (CPEB4) | Colon, Rectum | Prognosis | He X et al. Virchows Arch. 2017 |
1029 | Cytoplasmic polyadenylation element-binding protein 4 (CPEB4) | Colon, Rectum | Prognosis | He X et al. Virchows Arch. 2017 |
1030 | P-selectin | Colon | Prognosis | Korniluk A et al. Biomarkers. 2016 |
1032 | carboxypeptidaseA4 (CPA4) | Colon | Diagnosis | Sun L et al. Oncotarget. 2016 |
1033 | carboxypeptidaseA4 (CPA4) | Colon, Rectum | Prognosis | Sun L et al. Oncotarget. 2016 |
1034 | MFHAS1 | No Data | Prognosis | Chen W et al. Oncotarget. 2016 |
1040 | Circulating cellular DCLK1 protein (CCDP) | Colon, Rectum | Prognosis | Mirzaei A et al. Cancer Biomark. 2016 |
1041 | ING4 | Colon | Prognosis, Treatment | Chen Y et al. Oncotarget. 2016 |
1045 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Niedzwiecki D et al. Oncologist. 2017 |
1046 | Dual specificity phosphatase 5 (DUSP5) | Colon, Rectum | Prognosis | Yan X et al. Am J Cancer Res. 2016 |
1047 | Haemoglobin (HbA1c) | Colon, Rectum | Prognosis | Goh SN et al. Int J Colorectal Dis. 2017 |
1053 | Aurora kinase A (AURKA) | Colon, Rectum | Prognosis | Koh HM et al. J Pathol Transl Med. 2017 |
1057 | Periplakin (PPL) | Colon | Treatment | Li X et al. Biomed Pharmacother. 2017 |
1060 | Poly(C)-binding protein 1 (PCBP1) | Colon, Rectum | Treatment | Guo J et al. Oncotarget. 2017 |
1061 | Lysosomal acid phosphatase 2(ACP2) | Colon, Rectum | Prognosis | Lee YC et al. Oncotarget. 2017 |
1063 | Lactate dehydrogenase (LDH) | Colon, Rectum | Treatment | Marmorino F et al. Br J Cancer. 2017 |
1066 | Tumor necrosis factor receptor-associated protein 1 (TRAP1) | Colon, Rectum | Prognosis | Pak MG et al. Diagn Pathol. 2017 |
1067 | Histidine triad nucleotide-binding 2 (HINT2) | Colon, Rectum | Prognosis | Li W et al. Oncotarget. 2017 |
1071 | Claudin-3 | Colon, Rectum | Diagnosis, Prognosis | Li JY et al. Nan Fang Yi Ke Da Xue Xue Bao. 2017 |
1072 | Nm23-H1, p53 | Colon, Rectum | Prognosis | Wu Y et al. Oncol Lett. 2017 |
1074 | ADAMTS5 | Colon, Rectum | Prognosis | Haraguchi N et al. Mol Clin Oncol. 2017 |
1075 | Hyperplastic polyposis 1 (HPP1) | Colon, Rectum | Prognosis | Herbst A et al. Int J Cancer. 2017 |
1076 | Peroxiredoxin 2 (PRDX2) | Colon, Rectum | Prognosis | Peng L et al. Oncotarget. 2017 |
1077 | Transducin (β)-like 1 X-linked receptor 1 (TBL1XR1) | Colon, Rectum | Prognosis | Liu H et al. J Gastroenterol Hepatol. 2017 |
1079 | EDNRB | Colon, Rectum | Diagnosis | Mousavi Ardehaie R et al. Bioengineered. 2017 |
1080 | Kallikrein-related peptidase (KLK) | Colon, Rectum | Prognosis | Liu X et al. Biomed Pharmacother. 2017 |
1081 | Enhancer of zeste homolog 2 (EZH2) | Colon, Rectum | Prognosis | Yamamoto I et al. Oncotarget. 2017 |
1083 | Acyl-CoA synthetases (ACSL) | Colon, Rectum | Prognosis | Hartmann F et al. Pathol Res Pract. 2017 |
1086 | T-cell leukemia/lymphoma-1A (TCL1A) | Colon, Rectum | Prognosis | Li H et al. Biomed Pharmacother. 2017 |
1087 | Quaking RNA-binding protein (QKI) | Colon, Rectum | Prognosis | Iwata N et al. Anticancer Res. 2017 |
1090 | Programmed death-ligand 1 (PD-L1) | Colon, Rectum | Prognosis | Goltz D et al. Oncoimmunology. 2016 |
1091 | Macrophage inhibitory cytokine 1 (MIC-1/GDF15) | Colon, Rectum | Diagnosis, Prognosis | Wang X et al. Oncotarget. 2017 |
1092 | Soluble urokinase plasminogen activator receptor (suPAR) | Rectum | Prognosis | Riisbro R et al. Int J Biol Markers. 2005 |
1094 | Pituitary tumor transforming gene-1 (PTTG1) | Colon, Rectum | Prognosis | Ren Q et al. Biomed Pharmacother. 2017 |
1095 | Tissue transglutaminase (TG2) | Colon | Prognosis | Ayinde O et al. Oncotarget. 2017 |
1096 | NM23 | Colon, Rectum | Prognosis | Han W et al. J Huazhong Univ Sci Technolog Med Sci. 2017 |
1097 | MLH1 | Colon | Treatment | Hinrichsen I et al. Mol Carcinog. 2017 |
1098 | Soluble HLA-G (sHLA-G) | Colon, Rectum | Prognosis | Kirana C et al. Int J Cancer. 2017 |
1101 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Bendardaf R et al. Libyan J Med. 2017 |
1106 | Programmed death-ligand 1 (PD-L1) | Colon, Rectum | Prognosis | Koganemaru S et al. Cancer Sci. 2017 |
1107 | Fibrinogen | Colon, Rectum | Prognosis | Hong T et al. Cancer Biomark. 2017 |
1108 | Phosphorylase kinase β (PHKβ) | Colon, Rectum | Prognosis | Wang G et al. J Cancer Res Clin Oncol. 2017 |
1110 | H3.3B | Colon, Rectum | Prognosis | Ayoubi HA et al. J Gastrointest Oncol. 2017 |
1112 | Angiopoietin-2 (Ang-2) | Colon, Rectum | Prognosis | Hong S et al. Ann Coloproctol. 2017 |
1113 | E-cadherin | Colon, Rectum | Treatment | Christou N et al. J Cancer Res Clin Oncol. 2017 |
1114 | Cellular retinol binding protein 1 (CRBP1) | Colon, Rectum | Treatment | Yokoi K et al. Br J Cancer. 2017 |
1116 | Apolipoprotein A-I (ApoA-I) | Colon, Rectum | Prognosis | Quan Q et al. Transl Oncol. 2017 |
1117 | Matrix Metallopeptidase 9 (MMP-9) | Colon, Rectum | Diagnosis | Lorenc Z et al. Med Sci Monit. 2017 |
1118 | Homeobox B9 (HOXB9) | Colon, Rectum | Treatment | Carbone C et al. Clin Cancer Res. 2017 |
1121 | Mitogen-, stress-activated protein kinase 1 (MSK1) | Rectum | Prognosis | Fu X et al. Dig Liver Dis. 2017 |
1123 | Transducin (β)-like 1 X-linked receptor 1 (TBL1XR1) | Colon, Rectum | Prognosis | Liu H et al. Surg Oncol. 2017 |
1124 | Sulfatase-2 (SULF2) | Colon, Rectum | Prognosis | Tao Y et al. Biomed Pharmacother. 2017 |
1125 | Semaphorin 3D (SEMA3D) | Colon, Rectum | Diagnosis, Prognosis | Wang Z et al. World J Surg Oncol. 2017 |
1126 | DHX32 | Colon, Rectum | Diagnosis, Prognosis | Lin H et al. EBioMedicine. 2017 |
1128 | 4E‑binding protein 1 (p‑4E‑BP1) | Colon, Rectum | Prognosis | Miao Y et al. Mol Med Rep. 2017 |
1129 | KNG1, OLFM4, Sec24C | Colon, Rectum | Diagnosis | Quesada-Calvo F et al. Clin Proteomics. 2017 |
1130 | Mismatch repair genes (MMR) | Colon, Rectum | Prognosis | Li P et al. Cancer Med. 2017 |
1138 | Nicotinamide phosphoribosyl transferase (NAMPT) | Colon, Rectum | Prognosis | Pan, J H et al. J Cell Physiol. 2019 |
1139 | Serum CEA levels | No Data | No Data | Kawahara, H et al. Anticancer Res. 2018 |
1143 | C/EBPα | Colon, Rectum | Prognosis | Mi, L et al. Am J Cancer Res. 2018 |
1145 | SRPK1 | Colon, Rectum | Prognosis, Treatment | Yi, N et al. Onco Targets Ther. 2018 |
1146 | Thymidine kinase 1 (TK1) | No Data | No Data | Weagel, E G et al. Cancer Cell Int. 2018 |
1148 | Ras association domain family 1 isoform A (RASSF1A) | No Data | No Data | Oh, S J et al. J Gastroenterol Hepatol. 2019 |
1149 | MUC2 | Colon, Rectum | Prognosis | Al-Maghrabi, J et al. Saudi J Gastroenterol. 2019 |
1151 | KIF14 | Colon, Rectum | No Data | Wang, Z Z et al. Int J Oncol. 2018 |
1155 | CDX2 | No Data | No Data | Fiedler, D et al. Int J Cancer. 2019 |
1157 | SLC17A9 | No Data | Prognosis | Yang, L et al. Hum Pathol. 2019 |
1159 | FOXD4 | Colon, Rectum | Diagnosis, Treatment | Chen, C et al. Cancer Biol Ther. 2018 |
1160 | FOXF1 | No Data | No Data | Wang, S et al. Cancer Lett. 2018 |
1161 | CDX2 | No Data | No Data | Graule, J et al. Clin Epigenetics. 2018 |
1162 | Keratin 80 (KRT80) | Colon, Rectum | Prognosis | Li, C et al. Cell Death Dis. 2018 |
1163 | Monocarboxylate transporter 4 (MCT4) | Colon, Rectum | Prognosis | Abe, Y et al. Asia Pac J Clin Oncol. 2019 |
1167 | NOVA2 | No Data | No Data | Gallo, S et al. Onco Targets Ther. 2018 |
1169 | Large external antigen (LEA) | No Data | Prognosis | Yuan, D et al. Cancer Med. 2018 |
1171 | PBK/TOPK expression | No Data | Prognosis | Su, T C et al. PLoS One. 2018 |
1172 | preoperative C-reactive protein (CRP) | Rectum | Prognosis | Kim, W R et al. Ann Surg Oncol. 2018 |
1173 | Serum PTX3 | Colon, Rectum | Prognosis | Liu, B et al. Medicine (Baltimore). 2018 |
1174 | PPP2CA | Colon | Prognosis, Treatment | Yong, L et al. Int J Surg. 2018 |
1175 | cytoplasmic p21 | No Data | Prognosis, Treatment | Maiuthed, A et al. Cancers (Basel). 2018 |
1177 | ALDH1A1 | Colon, Rectum | Prognosis | van der Waals, L M et al. PLoS One. 2018 |
1184 | CDX2 | No Data | No Data | Shigematsu, Y et al. BMC Cancer. 2018 |
1186 | Transforming acidic coiled-coil protein-3 (TACC3) | Rectum | Prognosis | Ma, W J et al. Aging (Albany NY). 2018 |
1190 | AKIP1 | Colon, Rectum | Prognosis | Jiang, W et al. Onco Targets Ther. 2018 |
1192 | SETD7 | Colon, Rectum | No Data | Duan, B et al. EBioMedicine. 2018 |
1198 | protein O-fucosyltransferase 1 (POFUT1) | Colon, Rectum | Diagnosis | Chabanais, J et al. Cancers (Basel). 2018 |
1201 | ubiquitin‑like modifier‑activating enzyme 2 (UBA2) | Colon | Prognosis | He, P et al. Mol Med Rep. 2018 |
1202 | Stomatin-like protein-2 (SLP-2) | Colon, Rectum | Prognosis | Zhou, C et al. Pathol Res Pract. 2019 |
1204 | GPNMB | Colon | No Data | Ashktorab, H et al. BMC Cancer. 2018 |
1205 | Tie2 | No Data | No Data | Jayson, G C et al. Nat Commun. 2018 |
1207 | MORC2 (microrchidia family CW-type zinc finger 2) | No Data | No Data | Liu, J et al. Cancer Sci. 2019 |
1208 | Galectin-3 | No Data | Prognosis | Wang, Y et al. Cancer Cell Int. 2018 |
1211 | HER2 | No Data | Prognosis | Feng, Y et al. Eur J Surg Oncol. 2019 |
1213 | Bcl-2 | No Data | Treatment | Kim, B K et al. Br J Cancer. 2018 |
1214 | fibroblast growth factor 21 (FGF-21) | No Data | No Data | Qian, J et al. Br J Cancer. 2018 |
1215 | Stanniocalcin 2 (STC2) | Colon, Rectum | No Data | Wang, J et al. Onco Targets Ther. 2018 |
1216 | NEK2 | No Data | Prognosis | Ren, Q et al. Onco Targets Ther. 2018 |
1218 | LDHB-Ac-K329 | No Data | Prognosis | Shi, L et al. Mol Oncol. 2019 |
1224 | serum Hsp70 | Colon, Rectum | Prognosis | Graf, L et al. Cancer Biomark. 2018 |
1225 | RAGE and Yap1 expression | Colon, Rectum | Prognosis | Qian, F et al. Mol Carcinog. 2019 |
1226 | Tissue inhibitor of metalloproteinase-1 (TIMP-1) | No Data | Diagnosis | Meng, C et al. PLoS One. 2018 |
1228 | Globulin-to-albumin ratio | Colon, Rectum | Prognosis | Hachiya, H et al. Ann Gastroenterol Surg. 2018 |
1229 | CCNA2 | Colon, Rectum | Diagnosis | Gan, Y et al. Cancer Manag Res. 2018 |
1230 | selenoprotein | Colon, Rectum | Prognosis | Hughes, D J et al. Nutrients. 2018 |
1231 | Soluble ICAM-1 (sICAM-1) | Colon, Rectum | Prognosis | Schellerer, V S et al. Int J Colorectal Dis. 2019 |
1233 | CtIP | No Data | Prognosis | Chen, H et al. J Cell Physiol. 2019 |
1240 | cholesteryl ester transfer protein (CETP) mass | Colon, Rectum | Prognosis | Mihajlovic, M et al. Clin Biochem. 2019 |
1241 | β-1, 4-GalT-V | No Data | Diagnosis, Treatment | Chatterjee, S B et al. Biochem Biophys Res Commun. 2019 |
1248 | serum apolipoprotein A-I (ApoA-I) | No Data | No Data | Zhang, Y et al. Dis Markers. 2018 |
1250 | Gankyrin | No Data | Treatment | Sakurai, T et al. Digestion. 2018 |
1251 | IMPDH2 | Colon, Rectum | Prognosis | Duan, S et al. J Exp Clin Cancer Res. 2018 |
1252 | HCRP-1 | Colon | Prognosis | Chen, F et al. Cell Death Dis. 2018 |
1253 | Sox2 | No Data | No Data | Takeda, K et al. Sci Rep. 2018 |
1254 | TFEB | No Data | Prognosis | Liang, J et al. Onco Targets Ther. 2018 |
1256 | EphB3 | Colon, Rectum | Prognosis | Xuan, Z et al. Pathol Oncol Res. 2018 |
1259 | TMEM180 | No Data | No Data | Yasunaga, M et al. Cancer Sci. 2019 |
1260 | Yes-associated protein 1 (YAP1) | No Data | Prognosis | Zhang, L et al. Biomed Res Int. 2018 |
1262 | Heat shock protein 27 (HSP27) | No Data | No Data | Huang, C Y et al. Cells. 2018 |
1265 | NTSR1 | No Data | No Data | Suzuki, H et al. Digestion. 2019 |
1266 | sex determining region Y (SRY)-box 18 (SOX18) | Colon | Diagnosis, Prognosis | Miao, Z et al. Onco Targets Ther. 2018 |
1267 | CCBE1 | Colon, Rectum | Prognosis | Zhao, Y R et al. Cancer Manag Res. 2018 |
1272 | Loss of EphA3 expression | Colon, Rectum | No Data | Wang, Y et al. Dig Dis Sci. 2019 |
1273 | PRDX6 | Colon, Rectum | No Data | Huang, W S et al. Cell Physiol Biochem. 2018 |
1275 | H2AFJ | No Data | No Data | Wang, X et al. J Cell Biochem. 2019 |
1280 | thrombospondin 2 (THBS2) | No Data | Prognosis | Tian, Q et al. J buon. 2018 |
1284 | KDM3A | No Data | Prognosis | Liu, J et al. Int J Biol Macromol. 2019 |
1285 | AZIN1 | No Data | No Data | Takeda, S et al. Cancer Lett. 2019 |
1287 | SMAD4 | Colon | Prognosis | Wasserman, I et al. Clin Cancer Res. 2019 |
1291 | chemerin | No Data | No Data | Alkady, M M et al. J Med Biochem. 2018 |
1295 | PIK3CD | No Data | Prognosis | Chen, J S et al. Cancer Sci. 2019 |
1296 | phospholipase C delta1 (PLCD1) | Colon | Diagnosis, Prognosis | Xiang, Q et al. J Cell Physiol. 2019 |
1297 | betaII-Tubulin(βII) | Colon, Rectum | Prognosis | Ruksha, K et al. Cells. 2019 |
1298 | vastatin | Colon, Rectum | No Data | Willumsen, N et al. Cancer Biol Ther. 2019 |
1300 | IL-17RA | No Data | Prognosis | Yan, C et al. Int J Cancer. 2019 |
1302 | MAF1 | No Data | Prognosis | Hokonohara, K et al. Int J Oncol. 2019 |
1309 | TULP3 | No Data | Diagnosis, Prognosis | Sartor, I T S et al. PLoS One. 2019 |
1312 | ETS translocation variant 5 (ETV5) | Colon, Rectum | Diagnosis, Prognosis | Cheng, X et al. Int J Cancer. 2019 |
1314 | β6 -integrin (ITGB6) | No Data | Diagnosis, Prognosis | Bengs, S et al. Int J Cancer. 2019 |
1315 | Basic transcription factor 3 (BTF3) | No Data | Diagnosis, Treatment | Li, X et al. Oncol Lett. 2019 |
1321 | RNF152 | No Data | Prognosis | Cui, X et al. Am J Transl Res. 2018 |
1328 | Overexpression of EGFR-N | Rectum | No Data | Yang, C C et al. Oncol Lett. 2019 |
1331 | FGR+HCK | Colon, Rectum | Prognosis | Roseweir, A K et al. Cell Signal. 2019 |
1334 | Zyxin | No Data | Prognosis | Zhong, C et al. J Cell Physiol. 2019 |
1335 | TUBB3(betaIII-tubulin, βIII) | Colon | Prognosis | Oztop, S et al. Anticancer Res. 2019 |
1336 | SPHK1 | Colon, Rectum | Prognosis | Bae, G E et al. Anticancer Res. 2019 |
1338 | The combination of serum cholinesterase and albumin levels | Colon, Rectum | Prognosis | Yamamoto, M et al. Anticancer Res. 2019 |
1340 | ITGBL1 | Colon, Rectum | No Data | Matsuyama, T et al. Mol Cancer. 2019 |
1342 | Loss of YAP expression | Colon, Rectum | Prognosis | Zhang, S et al. J Cancer. 2019 |
1343 | AHR | No Data | No Data | Yamaguchi, M et al. Int J Oncol. 2019 |
1344 | GGN | No Data | No Data | Liu, Z et al. Pathol Oncol Res. 2019 |
1346 | high Ki-67 expression | No Data | Prognosis | Luo, Z W et al. BMC Cancer. 2019 |
1347 | ASPN | No Data | Prognosis | Li, H et al. Cell Death Dis. 2019 |
1350 | Msx1 | No Data | No Data | Horazna, M et al. Sci Rep. 2019 |
1351 | UCP1 | No Data | Prognosis | Alnabulsi, A et al. Int J Cancer. 2019 |
1353 | KLF14 | No Data | Prognosis | Wu, G et al. Int J Biol Sci. 2019 |
1355 | ACP5 | Colon, Rectum | Prognosis | Bian, Z Q et al. Am J Cancer Res. 2019 |
1356 | RNase 5 | No Data | No Data | Wang, W J et al. Am J Cancer Res. 2019 |
1357 | KLK5 | No Data | Prognosis | Papachristopoulou, G et al. Clin Chem Lab Med. 2019 |
1358 | Layilin (LAYN) | Colon | Prognosis | Pan, J H et al. Front Immunol. 2019 |
1359 | Runt-related transcription factor (RUNX) 3 | Colon, Rectum | No Data | Shinagawa, T et al. Digestion. 2019 |
1360 | AZIN2 | No Data | Prognosis | Kaprio, T et al. PLoS One. 2019 |
1361 | Spalt-like transcription factor 4 (SALL4) | No Data | Diagnosis, Treatment | Hesari, A et al. J Cell Biochem. 2019 |
1362 | Human epidermal growth factor 2 (HER2) | Rectum | No Data | Kwon, M J et al. Pathol Res Pract. 2019 |
1364 | RIPK3 | No Data | No Data | Jayakumar, A et al. Cancer Res. 2019 |
1368 | KIR2DS4 | Colon, Rectum | Prognosis | Borrero-Palacios, A et al. Sci Rep. 2019 |
1372 | MACC1 | Colon, Rectum | Prognosis | Lin, A et al. Front Oncol. 2019 |
1378 | mucin 1 (MUC1) | No Data | No Data | Li, C et al. Medicine (Baltimore). 2019 |
1379 | serum CEA | Colon, Rectum | No Data | Baqar, A R et al. Int J Surg. 2019 |
1381 | EPHA2 | Colon, Rectum | Prognosis, Treatment | Martini, G et al. Mol Cancer Ther. 2019 |
1384 | Annexin A1(ANXA1) | Colon | Prognosis | Rubinstein, M R et al. EMBO Rep. 2019 |
1385 | d16HER2 | No Data | No Data | Volpi, C C et al. Sci Rep. 2019 |
1386 | preoperative CA 19-9 level | Colon, Rectum | Prognosis | Shin, J K et al. Ann Surg Treat Res. 2019 |
1388 | ABHD5 | No Data | No Data | Ou, J et al. Nat Commun. 2019 |
1390 | cathepsin K (CTSK) | No Data | No Data | Li, R et al. Cell Death Differ. 2019 |
1391 | SFRP2 methylation | Colon, Rectum | No Data | Li, H et al. Int J Biol Markers. 2019 |
1392 | serum CEA level | Colon, Rectum | Prognosis | Ramphal, W et al. Int J Biol Markers. 2019 |
1394 | HCP5, EPB41L4A-AS1, SNHG12, and LINC00649 | No Data | Diagnosis | He, M et al. Oncol Lett. 2019 |
1396 | FLOT2 | Colon, Rectum | Prognosis | Li, T et al. Oncol Lett. 2019 |
1398 | MYH9 | No Data | Diagnosis, Treatment | Wang, B et al. J Cancer. 2019 |
1399 | SPTAN1 | No Data | Prognosis | Ackermann, A et al. PLoS One. 2019 |
1400 | SOX12 | No Data | Prognosis | Du, F et al. Cell Death Dis. 2019 |
1402 | STC2 | Colon, Rectum | Prognosis | Zhang, C et al. Onco Targets Ther. 2019 |
1403 | Smurf2 | Colon, Rectum | Prognosis | Klupp, F et al. Cancer Manag Res. 2019 |
1406 | CCL5 | Colon, Rectum | No Data | Chen, M et al. Pathol Res Pract. 2019 |
1408 | programmed death-ligand 1 (PD-L1) | No Data | Prognosis | Li, Y et al. Front Pharmacol. 2019 |
1409 | programmed death-ligand 1 (PD-L1) | No Data | No Data | Li, Z et al. Int J Cancer. 2019 |
1412 | P zero-related protein (PZR) | No Data | Diagnosis, Prognosis | Tan, D et al. Acta Biochim Biophys Sin (Shanghai). 2019 |
1414 | MUC1 | Rectum | No Data | Sun, Y et al. Eur J Surg Oncol. 2019 |
1417 | CD133 and CD44 | Colon, Rectum | No Data | Chaitra, L P et al. J Cancer Res Ther. 2019 |
1423 | Arginase-1 (Arg-1) | Colon, Rectum | No Data | Ma, Z et al. Pathol Res Pract. 2019 |
1425 | IGF2BP3 | Colon, Rectum | Prognosis | Xu, W et al. J Cell Physiol. 2019 |
1427 | RIPK3 | No Data | Prognosis | Conev, N V et al. Clin Invest Med. 2019 |
1429 | Carcinoembryonic antigen (CEA) | No Data | No Data | Hao, C et al. Prog Mol Biol Transl Sci. 2019 |
1430 | serum CA242 | No Data | No Data | Dou, H et al. Prog Mol Biol Transl Sci. 2019 |
1431 | VASP protein, pSer157-VASP, and pSer239-VASP | Colon | Prognosis | Pitari, G M et al. Biomark Cancer. 2018 |
1439 | NT5E | No Data | Diagnosis, Prognosis | Wang, G et al. Cancer Biomark. 2019 |
1440 | Defensin alpha 6 (DEFA6) | Colon, Rectum | Prognosis | Jeong, D et al. Cancer Biomark. 2019 |
1441 | multidrug resistance-associated protein 1 (MRP-1) | Colon, Rectum | Diagnosis, Prognosis | Yang, J et al. J buon. 2019 |
1442 | RARβ | Colon, Rectum | Prognosis | Wang, W et al. Dis Markers. 2019 |
1443 | LTBP2 | Colon, Rectum | Prognosis | Huang, Y et al. Dis Markers. 2019 |
1446 | JAM3 | Colon, Rectum | Diagnosis | Zhou, D et al. Cancer Manag Res. 2019 |
1447 | nerve/glial antigen 2 (NG2) | Colon, Rectum | Prognosis | Cengiz C et al. Digestion. 2017 |
1448 | High-temperature requirement A3 (HtrA3) | Colon, Rectum | Prognosis | Forse CL et al. Exp Mol Pathol. 2017 |
1449 | Proteasome subunit beta type-8(PSMB8) | Rectum | Prognosis | Ha YJ et al. Int J Radiat Oncol Biol Phys. 2017 |
1450 | Downregulation of Mucin 2 (MUC2) | Colon | Prognosis | Hsu HP et al. Sci Rep. 2017 |
1451 | insulin-like growth factor 2(IGF2) | Colon, Rectum | Prognosis | Sanderson MP et al. Mol Cancer Ther. 2017 |
1454 | Ki67 | Colon, Rectum | Diagnosis | Yang Y et al. Anticancer Res. 2017 |
1456 | Galectin-3 | Colon, Rectum | Prognosis | Tao L et al. Open Med (Wars). 2017 |
1457 | Krüppel-like factor 4(KLF4) | Colon, Rectum | Treatment | Jie Y et al. Cancer Gene Ther. 2017 |
1458 | versican (VCAN) | Colon, Rectum | Diagnosis, Prognosis | Hope C et al. J Immunol. 2017 |
1459 | telomerase reverse transcriptase gene(TERT) Promoter Hypermethylation | Colon, Rectum | Prognosis | Liu L et al. Oncologist. 2017 |
1461 | polymorphism in ATP-binding cassette subfamily C member 4 (ABCC4) | Colon, Rectum | Treatment | Chen Q et al. Sci Rep. 2017 |
1462 | Plant homeo domain finger protein 8 (PHF8) | Colon, Rectum | Diagnosis, Prognosis, Treatment | Lv Y et al. Mol Med Rep. 2017 |
1463 | Endothelial Protein C Receptor (EPCR) | Colon, Rectum | Prognosis | Neeraj Lal et al. J Pathol Clin Res. 2017 |
1465 | glutathione (GSH) | Colon, Rectum | Prognosis | Baltruskeviciene E et al. Tumori. 2018 |
1466 | mammary serine protease inhibitor(maspin) | Colon, Rectum | Prognosis | Banias L et al. Pathol Res Pract. 2017 |
1467 | methylenetetrahydrofolate reductase(MTHFR) genotype | Colon, Rectum | Prognosis | Kim KR et al. Oncol Lett. 2017 |
1468 | X-ray repair cross complementing 1 (XRCC1) (AG/AA) | Colon, Rectum | Diagnosis | Li J et al. Gene. 2017 |
1469 | CKLF-like MARVEL transmembrane domain 3 (CMTM3) | Colon, Rectum | Diagnosis | Li J et al. Gene. 2017 |
1470 | Somatostatin receptor 2(SSTR2) | Colon, Rectum | Diagnosis | Li J et al. Gene. 2017 |
1471 | CMTM3 + SSTR2 | Colon, Rectum | Diagnosis | Li J et al. Gene. 2017 |
1472 | CMTM3 + MDFI | Colon, Rectum | Diagnosis | Li J et al. Gene. 2017 |
1473 | SSTR2 + MDFI | Colon, Rectum | Diagnosis | Li J et al. Gene. 2017 |
1474 | CMTM3 + SSTR2 + MDFI | Colon, Rectum | Diagnosis | Li J et al. Gene. 2017 |
1475 | Ras-related protein 3C (RAB3C) | Colon, Rectum | Prognosis | Chang YC et al. Mol Cancer. 2017 |
1476 | B-cell lymphoma-2(bcl-2) | Colon, Rectum | Prognosis | Huang Q et al. World J Gastroenterol. 2018 |
1479 | Alpha B-crystallin (HspB5) | Colon, Rectum | Diagnosis, Prognosis | Li Q et al. PLoS One. 2017 |
1480 | Chemotherapy-associated hemoglobin | Colon, Rectum | Prognosis | Wei YS et al. Cancer Biomark. 2017 |
1481 | RNA-binding motif protein 3 (RBM3) | Colon, Rectum | Prognosis | Siesing C et al. PLoS One. 2017 |
1482 | melanoma 2 (AIM2) | Colon, Rectum | Prognosis | Zhang Z et al. Biomed Pharmacother. 2017 |
1483 | Cacna1g | Colon, Rectum | Prognosis | Ha SE et al. PLoS One. 2017 |
1484 | carbohydrate antigen 19-9(CA19-9) | Colon, Rectum | Prognosis | Akgül Ö et al. World J Gastrointest Oncol. 2017 |
1485 | DAND5(COCO) | Colon, Rectum | Prognosis | Miao X et al. United European Gastroenterol J. 2017 |
1486 | Centromere protein H (CENPH) | Colon, Rectum | Prognosis | Wu W et al. J Cancer. 2017 |
1487 | Empty Spiracles Homeobox (EMX-) 2 | Colon, Rectum | Prognosis | Aykut B et al. BMC Cancer. 2017 |
1490 | cation transport regulator-like protein 2(CHAC2) | Colon, Rectum | Prognosis | Liu S et al. Cell Death Dis. 2017 |
1491 | PROX1 | Colon, Rectum | Prognosis | Laitinen A et al. PLoS One. 2017 |
1492 | anti-p53 antibody (Ap53Ab) | Colon, Rectum | Diagnosis | Kumamoto K et al. Mol Clin Oncol. 2017 |
1494 | carbohydrate antigen (CA)19-9 | Rectum | Prognosis | Miki H et al. Dig Surg. 2018 |
1496 | carbohydrate antigen (CA)19-9 | Colon, Rectum | Prognosis | Komori A et al. Oncology. 2017 |
1497 | spalt-like transcription factor 4 (SALL4) | Colon, Rectum | Diagnosis, Prognosis | Wu HK et al. Cancer Biomark. 2017 |
1499 | Karyopherin α-2( KPNA2) | Colon, Rectum | Prognosis, Treatment | Jeong D et al. J Cancer Res Clin Oncol. 2017 |
1500 | S100A16 | Colon, Rectum | Prognosis, Treatment | Sun X et al. J Surg Oncol. 2018 |
1501 | CNRIP1, FBN1, INA, MAL, SNCA, and SPG20 | Colon | Prognosis | Guro E Lind et al. Clin Epigenetics. 2017 |
1503 | Aldehyde dehydrogenase (ALDH)1B1 | Colon, Rectum | Diagnosis | Matsumoto A et al. Br J Cancer. 2017 |
1504 | DNA hypomethylation of cystathionine beta synthase(CBS) | Colon, Rectum | Prognosis | Xue G et al. Oncotarget. 2017 |
1506 | 25-hydroxyvitamin D (25(OH)D3) | Colon, Rectum | Prognosis | Maalmi H et al. Eur J Epidemiol. 2017 |
1507 | Colon cancer secreted protein-2 (CCSP-2) | Colon, Rectum | Diagnosis, Prognosis | Kim J et al. Neoplasia. 2017 |
1508 | family member 3 (MIER3) | Colon, Rectum | Prognosis | Peng M et al. Sci Rep. 2017 |
1509 | human epididymis protein 4 (HE4) | Colon, Rectum | Diagnosis | Kemal YN et al. Mol Clin Oncol. 2017 |
1510 | α7nAChR | Colon, Rectum | Prognosis | Fei R et al. Oncol Rep. 2017 |
1511 | serum carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Sun Z et al. Oncotarget. 2017 |
1512 | Ras association domain family (RASSF) 6 | Colon, Rectum | Prognosis | Tutino V et al. Oncotarget. 2017 |
1513 | FN1 (Fibronectin 1) | Colon, Rectum | Prognosis | Gonçalves-Ribeiro S et al. Ann Oncol. 2017 |
1514 | Transcription factor activating enhancer binding protein 4 (TFAP4) | Colon, Rectum | Prognosis | Wei J et al. Exp Ther Med. 2017 |
1515 | SETDB1 (SET Domain Bifurcated Histone Lysine Methyltransferase 1) | Colon | Prognosis | Ho YJ et al. APMIS. 2017 |
1516 | Tripartite motif containing 24 (TRIM24) | Colon, Rectum | Prognosis | Wang FQ et al. Pathol Res Pract. 2017 |
1518 | PD-L1(CD274) | Colon, Rectum | Prognosis | Marisa L et al. J Natl Cancer Inst. 2017 |
1519 | haloacid dehalogenase-like hydrolase domain-containing 1 (HDHD1) Antisense RNA transcripts | Colon, Rectum | Diagnosis | Tomohiro Kurokawa et al. Oncol Lett. 2017 |
1520 | truncated neurokinin-1 receptors (tr-NK-1R) | Colon, Rectum | Diagnosis, Treatment | Gao X et al. Oncol Lett. 2017 |
1522 | IQ-motif containing GTPase activating protein 1 (IQGAP1) | Colon, Rectum | Diagnosis, Treatment | Rotoli D et al. Oncol Lett. 2017 |
1523 | dual oxidase 2 (DUOX2) | Rectum | Prognosis | Lin SC et al. J Cancer. 2017 |
1524 | Programmed death-1 (PD-1) | Colon, Rectum | Prognosis | Kollmann D et al. Oncoimmunology. 2017 |
1525 | Phosphorylated C-X-C Motif Chemokine Receptor 4(pCXCR4) | Colon, Rectum | Prognosis | Weixler B et al. Cell Oncol (Dordr). 2017 |
1526 | Beclin 1 | Colon, Rectum | Prognosis | Zhao H et al. Oncotarget. 2017 |
1528 | Phospholipase D1( PLD1) | Colon, Rectum | Prognosis | Kang DW et al. Clin Cancer Res. 2017 |
1529 | the chromatin remodeller polybromo-1 (PBRM1) | Colon, Rectum | Prognosis | Shu XS et al. J Pathol. 2018 |
1530 | Cannabinoid Receptor Interacting Protein 1( CNRIP1) | Colon, Rectum | Diagnosis, Treatment | Huang Q et al. J Mass Spectrom. 2017 |
1531 | Bactericidal or permeability-increasing protein fold-containing family A member 1 (BPIFA1) | Colon, Rectum | Prognosis | Wang H et al. Oncol Lett. 2017 |
1533 | lysyl oxidase (LOX) | Rectum | Prognosis | Liu N et al. Oncotarget. 2016 |
1534 | high mobility group AT-hook 2( HMGA2) | Colon, Rectum | Diagnosis | Sahengbieke S et al. J Clin Lab Anal. 2018 |
1535 | ezrin | Colon, Rectum | Prognosis | Slik K et al. PLoS One. 2017 |
1537 | Spleen Tyrosine Kinase (SYK) | Colon, Rectum | Prognosis | Coebergh van den Braak RRJ et al. PLoS One. 2017 |
1539 | methylated Decoy Receptor 1 (DCR1) | Colon, Rectum | Prognosis | Bosch LJW et al. Oncotarget. 2017 |
1541 | CD166 | Colon, Rectum | Prognosis | Han S et al. Oncotarget. 2017 |
1543 | heat shock protein 110 (HSP110) | Colon, Rectum | Prognosis | Oh HJ et al. APMIS. 2017 |
1544 | BRAFnon-V600E mutations | Colon, Rectum | Prognosis | Eiji Shinozaki et al. Br J Cancer. 2017 |
1546 | XRCC2 | Colon, Rectum | Prognosis | Zhang Y et al. Cell Physiol Biochem. 2017 |
1547 | carbohydrate antigen 19-9(CA19-9) | Colon, Rectum | Diagnosis | Zhao JX et al. Oncotarget. 2017 |
1549 | five-gene methylation panel (EYA4, GRIA4, ITGA4, MAP3K14-AS1, MSC) | Colon, Rectum | Prognosis | Barault L et al. Gut. 2018 |
1550 | NOTCH1 (Notch Receptor 1) | Colon, Rectum | Diagnosis | Li G et al. Future Oncol. 2017 |
1551 | Mindin | Colon, Rectum | Diagnosis | Wang LF et al. Oncogene. 2018 |
1552 | combination of ENT1, MATE1 and OCT2 SNPs | Colon, Rectum | Diagnosis, Prognosis | Suenaga M et al. Eur J Cancer. 2017 |
1553 | collagen I (Col-I) | Rectum | Prognosis | Blockhuys S et al. J Biomed Opt. 2017 |
1554 | tumor-infiltrating tryptase+ mast cells | Colon, Rectum | Prognosis | Hu G et al. Int J Cancer. 2018 |
1555 | Myosin Vb (MYO5B) | Colon, Rectum | Prognosis | Letellier E et al. Br J Cancer. 2018 |
1556 | Leucine-rich alpha-2-glycoprotein-1 (encoded by LRG1) | Colon, Rectum | Prognosis | Sun DC et al. Oncotarget. 2017 |
1558 | hypermethylation of paired boxed gene 1 (PAX1) | Colon, Rectum | Diagnosis | Huang J1 et al. Onco Targets Ther. 2017 |
1559 | YY1AP1 (YY1 Associated Protein 1) | Colon | Prognosis | Ho YJ et al. Biochem Biophys Res Commun. 2017 |
1561 | MAPK-interacting kinase 1 (MKNK1) (MKNK1 polymorphism rs8602) | Colon, Rectum | Prognosis, Treatment | Berger MD et al. Ann Oncol. 2017 |
1562 | Ras association domain protein 10 (RASSF10) | Colon, Rectum | Prognosis | Ma J et al. Medicine (Baltimore). 2017 |
1563 | phosphatase of regenerating liver-3 (PRL-3) | Colon, Rectum | Prognosis | Lan Q et al. Mol Cancer Ther. 2018 |
1564 | Paternally expressed gene-10 (PEG10) | Colon, Rectum | Diagnosis | Li B et al. J Cell Biochem. 2018 |
1565 | TNC (Tenascin C) | Colon, Rectum | Prognosis | Murakami T et al. Br J Cancer. 2017 |
1566 | Hepatocyte nuclear factor 1-alpha (HNF1A) rs2244608 | Colon, Rectum | Prognosis | Labriet A et al. Front Pharmacol. 2017 |
1567 | ribophorin II (RPN2) | Colon, Rectum | Prognosis, Treatment | Li H et al. Oncotarget. 2017 |
1569 | panel of four antibodies (anti-SLP2, -p53, -SEC61B, and -PLSCR1) | Colon, Rectum | Diagnosis | Fan CW et al. Clin Chim Acta. 2018 |
1571 | CTNNB1 (β-catenin) | Colon, Rectum | Prognosis | Chiarotto JA et al. Cancer Manag Res. 2017 |
1572 | Zinc finger protein 331 (ZNF331) | Colon, Rectum | Prognosis | Wang Y et al. Clin Epigenetics. 2017 |
1573 | HER3 | Colon, Rectum | Prognosis | Seligmann JF et al. JAMA Oncol. 2018 |
1574 | serine/threonine kinase 4 (STK4, also known as MST1) | Colon, Rectum | Diagnosis | Yu J et al. Sci Rep. 2017 |
1576 | E-cadherin | Colon, Rectum | Prognosis | Yan X et al. Onco Targets Ther. 2017 |
1577 | angiotensin converting enzyme (ACE) | Colon, Rectum | Prognosis | Marques D et al. World J Gastroenterol. 2017 |
1578 | Golgi-associated PDZ- and coiled-coil motif-containing (GOPC) | Colon, Rectum | Prognosis | Ohara N et al. Oncol Lett. 2017 |
1579 | MERTK (MER Proto-Oncogene, Tyrosine Kinase) | Colon, Rectum | Prognosis | Frejno M et al. Mol Syst Biol. 2017 |
1582 | Flap endonuclease 1 (FEN1) | Colon, Rectum | Prognosis | Chou AK et al. Cancer Genomics Proteomics. 2017 |
1583 | VEGF | Colon, Rectum | Prognosis | Mohamed SY et al. J Gastrointest Cancer. 2017 |
1584 | lysosome-associated protein transmembrane 4β (LAPTM4β) | Colon, Rectum | Prognosis | Huang YN et al. Oncol Lett. 2017 |
1585 | macrophage-capping protein (CapG) | Colon, Rectum | Prognosis | Wu W et al. Oncol Lett. 2017 |
1586 | Jun activation domain-binding protein 1 (JAB1) | Colon, Rectum | Diagnosis | Kugimiya N et al. Oncol Lett. 2017 |
1587 | LOXL2 (lysyl oxidase-like 2) | Colon, Rectum | Prognosis | Park PG et al. Oncotarget. 2017 |
1588 | ALU115 | Colon, Rectum | Diagnosis | Bhangu JS et al. Surg Oncol. 2017 |
1592 | Somatic v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutation | Colon, Rectum | Prognosis | Kayhanian H et al. Clin Colorectal Cancer. 2018 |
1593 | Heat shock factor 4 (HSF4) | Colon, Rectum | Prognosis | Yang Y et al. IUBMB Life. 2017 |
1594 | oestrogen receptor-β (ERβ) | Colon, Rectum | Prognosis | Stevanato Filho PR et al. BMC Cancer. 2017 |
1595 | WBSCR22 | Colon, Rectum | Prognosis | Yan D et al. Sci Rep. 2017 |
1596 | S-phase kinase associated protein 2(spk2) | Colon, Rectum | Prognosis | Vasile Bochis O et al. J BUON. 2017 |
1597 | canopy fibroblast growth factor signaling regulator 2 (CNPY2) | Colon, Rectum | Prognosis | Peng et al. Aging (Albany NY). 2017 |
1599 | N-myc downstream-regulated gene 1(NDRG1)) | Colon, Rectum | Prognosis | Zhang X et al. Oncotarget. 2017 |
1601 | Tissue factor pathway inhibitor 2 (TFPI2)hypermethylation | Colon, Rectum | Prognosis | Hu H et al. Oncotarget. 2017 |
1602 | phosphatidylinositol 3-kinase (PI3K) | Colon, Rectum | Prognosis | Laes JF et al. Oncotarget. 2017 |
1603 | p53 upregulated modulator of apoptosis (PUMA) | Colon | Prognosis | Guo L et al. Onco Targets Ther. 2017 |
1604 | serum epidermal growth factor receptor (sEGFR) | Colon, Rectum | Prognosis | Karabulut M et al. Mol Clin Oncol. 2017 |
1605 | Placental-Cadherin (CDH3) | Colon, Rectum | Prognosis | Kumara HMCS et al. Oncoscience. 2017 |
1606 | A disintegrin and metalloprotease with motif 5(ADAMTS5) | Colon, Rectum | Prognosis | Li J et al. J Cancer Res Clin Oncol. 2017 |
1609 | Ubiquinol cytochrome c reductase binding protein (UQCRB) | Colon, Rectum | Prognosis | Kim HC et al. Exp Mol Med. 2017 |
1610 | RASSF1A methylation | Colon, Rectum | Prognosis, Treatment | Opinto G et al. Oncotarget. 2017 |
1611 | tumor suppressor candidate-3 (TUSC3/N33) | Colon, Rectum | Prognosis | Burgermeister E et al. Oncotarget. 2017 |
1612 | Immunoglobulin (Ig) A | Colon, Rectum | Prognosis | Carpenet H et al. Oncotarget. 2017 |
1613 | FAM132B, CPB1, NXPH4, OSR1, PCOLCE2, RNF112, TNNT2, GABRD, MIR27A, HOTAIR, MMP1, MS4A1, IZUMO2, GIF | Colon, Rectum | Prognosis | Tang JY et al. Cell Cycle. 2018 |
1614 | C-X-C Motif Chemokine Ligand 9(CXCL9) | Colon, Rectum | Prognosis | Kistner L et al. Oncotarget. 2017 |
1616 | Pim-3 | Colon, Rectum | Prognosis | Zhang RX et al. Sci Rep. 2017 |
1617 | RP11-3N2.1 | Colon, Rectum | Prognosis | Ye D et al. J Hum Genet. 2017 |
1619 | P16ink4a | Colon, Rectum | Prognosis | Charkhat Gorgich EA et al. Asian Pac J Cancer Prev. 2017 |
1620 | Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) | Colon, Rectum | Prognosis | Yamaguchi S et al. J Surg Res. 2017 |
1621 | MutS Homolog 2( MSH2 ) | Colon | Prognosis | Mik M et al. Arch Med Sci. 2017 |
1623 | T16189C | Colon, Rectum | Diagnosis | Kumar B et al. Tumour Biol. 2017 |
1624 | GDF-15, AREG, FasL, Flt3L and TP53 autoantibody | Colon, Rectum | Prognosis | Chen H et al. Clin Epidemiol. 2017 |
1627 | DNA repair protein RAD50 homolog(RAD50) | Rectum | Prognosis | Ho V et al. Cancers (Basel). 2017 |
1628 | Retinol Binding Protein 4(RBP4 ) | Colon, Rectum | Diagnosis | Fei W et al. Oncotarget. 2017 |
1629 | Ezrin | Colon, Rectum | Prognosis | Liang F et al. Oncotarget. 2017 |
1630 | serine peptidase inhibitor Kazal type 1 (SPINK1) | Colon, Rectum | Prognosis, Treatment | Räsänen K et al. Mol Oncol. 2018 |
1631 | FUT9 (Fucosyltransferase 9) | Colon, Rectum | Prognosis | Auslander N et al. Mol Syst Biol. 2017 |
1632 | T-box 19 (TBX19) | Colon, Rectum | Prognosis | Ando J et al. Fukushima J Med Sci. 2017 |
1633 | KRAS | Colon, Rectum | Diagnosis | Greenbaum A et al. Heliyon. 2017 |
1634 | Carcinoembryonic antigen (CEA) and MSI status | Colon, Rectum | Prognosis | Koyel B et al. Indian J Surg Oncol. 2017 |
1635 | Kirsten Ras (KRAS) | Colon | Diagnosis | Smitha CS et al. Indian J Surg Oncol. 2017 |
1636 | glucose transporter 1 (GLUT1) | Colon, Rectum | Prognosis | GabAllah GMK et al. Saudi J Gastroenterol. 2017 |
1638 | GC rs4588 | Colon, Rectum | Diagnosis | Berger MD et al. Clin Cancer Res. 2018 |
1641 | octamer-binding transcription factor 4 (OCT4) | Colon, Rectum | Prognosis | You L et al. Yonsei Med J. 2018 |
1642 | Reticulocalbin 2 (RCN2) | Colon, Rectum | Prognosis | Wang G et al. Am J Cancer Res. 2017 |
1644 | NHLRC3, ZDHHC21, PRR14L, CCBL1, PTPRB, PNPO, and PPIP5K2 | Colon, Rectum | Prognosis | Chen H et al. Oncotarget. 2016 |
1646 | SDC2 methylation | Colon, Rectum | Prognosis | Oh TJ et al. Clin Epigenetics. 2017 |
1647 | LIM and SH3 protein 1 (LASP1) | Colon, Rectum | Prognosis | Zhou R et al. Int J Cancer. 2018 |
1650 | Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) | Colon, Rectum | Prognosis | Benlahfid M et al. Cancer Biomark. 2018 |
1651 | mannose receptor (MR) | Colon, Rectum | Diagnosis | Ding D et al. Cancer Biomark. 2018 |
1653 | VEGFD (Vascular Endothelial Growth Factor D) | Colon, Rectum | Prognosis | Tabernero J et al. Ann Oncol. 2018 |
1656 | Src homology-2 domain-containing phosphatase(SHP2) AND STAT3 | Colon, Rectum | Prognosis | Huang Y et al. Sci Rep. 2017 |
1659 | ATP-binding cassette (ABC) drug transporter ABCG2 | Colon, Rectum | Treatment | Hsu HH et al. J Cell Physiol. 2018 |
1660 | leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) | Rectum | Prognosis | Harada Y et al. Oncol Lett. 2017 |
1662 | glypican-1 positive (GPC1+) | Colon, Rectum | Prognosis | Li J et al. Oncotarget. 2017 |
1663 | MPG (N-Methylpurine DNA Glycosylase) | Colon, Rectum | Prognosis | Azambuja DB et al. Pathol Res Pract. 2018 |
1664 | p53 antibodies | Colon, Rectum | Prognosis | Teras LR et al. Cancer Epidemiol Biomarkers Prev. 2018 |
1665 | Nebulette (NEBL) | Colon, Rectum | Prognosis | Qiu X et al. Mol Med Rep. 2018 |
1666 | wee1 | Colon, Rectum | Prognosis | Yin Y et al. Mol Med Rep. 2018 |
1667 | thymidylate synthase (TYMS) | Colon, Rectum | Diagnosis | Castro-Rojas CA et al. Drug Metab Pers Ther. 2017 |
1668 | RNA-Binding Motif Protein 3 (RBM3) | Colon, Rectum | Prognosis | Ye F et al. Med Sci Monit. 2017 |
1669 | Podoplanin (PDPN) | Rectum | Diagnosis | Zhao X et al. Cancer Sci. 2018 |
1670 | Kelch Repeat And BTB Domain Containing 11(KBTBD11) | Colon, Rectum | Prognosis | Gong J et al. Ann Oncol. 2018 |
1671 | C-C motif chemokine receptor 6 (CCR6) | Colon, Rectum | Prognosis | Chang H et al. Cancer Res Treat. 2018 |
1672 | Special AT-rich sequence-binding protein 2 (SATB2) | Colon, Rectum | Diagnosis | Ramos BD et al. Appl Immunohistochem Mol Morphol. 2017 |
1673 | CD86 | Colon, Rectum | Diagnosis | Peyravian N et al. Curr Res Transl Med. 2018 |
1674 | Mitochondrial transcription factor A (mtTFA) | Colon, Rectum | Prognosis | Katsuki T et al. Anticancer Res. 2018 |
1676 | CLDN3 (Claudin 3) | Colon, Rectum | Prognosis | Tokuhara Y et al. Oncol Lett. 2018 |
1677 | E3 ubiquitin ligase RNF6 (RING-finger protein 6) | Colon, Rectum | Prognosis | Liang Q et al. Clin Cancer Res. 2018 |
1678 | Transforming growth factor-β-activated kinase 1 (TAK1)-binding protein 3 (TAB3) | Colon, Rectum | Prognosis | Luo C et al. Oncotarget. 2018 |
1679 | EZR (Ezrin) | Colon, Rectum | Prognosis | Mori K et al. Oncotarget. 2017 |
1680 | E3 ubiquitin protein UBR5 | Colon, Rectum | Prognosis | Xie Z et al. Oncotarget. 2017 |
1681 | Amphiregulin (AREG) | Colon, Rectum | Prognosis | Chayangsu C et al. J Gastrointest Oncol. 2017 |
1683 | Low density lipoprotein (LDL) receptor-related protein-6 (LRP6) | Colon, Rectum | Prognosis | Yao Q et al. Oncotarget. 2017 |
1684 | meEGFR-CTCs | Colon, Rectum | Prognosis | Korphaisarn K et al. Am J Cancer Res. 2017 |
1685 | FAM134B methylation | Colon, Rectum | Prognosis | Islam F et al. Genes Chromosomes Cancer. 2018 |
1686 | CD8 | Colon, Rectum | Prognosis | James Ziai et al. PLoS One. 2018 |
1687 | RAD50 | Colon, Rectum | Prognosis | Chen C et al. Neoplasma. 2018 |
1689 | CD133 | Colon, Rectum | Prognosis | Nagata H et al. Int J Oncol. 2018 |
1691 | Hypermethylation of Runt-related transcription factors (RUNXs) | Colon, Rectum | Prognosis | Shin EJ et al. Ann Surg Treat Res. 2018 |
1693 | phosphorylation of Signal Transducers and Activators of Transcription 3 (p-STAT3) | Colon, Rectum | Prognosis | Han C et al. Technol Cancer Res Treat. 2018 |
1694 | ribose-5-phosphate isomerase A (RPIA) | Colon, Rectum | Prognosis, Treatment | Chou YT et al. PLoS Biol. 2018 |
1695 | caveolin-1 (Cav-1) | Colon, Rectum | Prognosis | Yang J et al. Med Sci Monit. 2018 |
1696 | RIP140 (Receptor Interacting Protein of 140kDa) | Colon, Rectum | Prognosis | Triki M et al. Oncotarget. 2017 |
1698 | Nuclear division cycle 80 (NDC80) | Colon, Rectum | Prognosis | Yan X et al. Cancer Med. 2018 |
1699 | S6 kinase 2 (S6K2) | Colon, Rectum | Treatment | Sun Y et al. Oncol Lett. 2017 |
1701 | livin | Rectum | Prognosis | Su QB et al. Oncol Lett. 2017 |
1702 | Phosphoserine aminotransferase 1 (PSAT1) | Colon, Rectum | Prognosis | Qian C et al. Oncol Lett. 2017 |
1703 | Heat shock transcription factor-1 (HSF-1) | Colon, Rectum | Prognosis | Bhardwaj M et al. Oncotarget. 2017 |
1704 | ST6 N-Acetylgalactosaminide Alpha-2, 6-Sialyltransferase 1 (ST6GalNAC1) | Colon, Rectum | Treatment | Ogawa T et al. Oncotarget. 2018 |
1705 | LIM kinases 1 | Colon, Rectum | Prognosis | Aggelou H et al. Virchows Arch. 2018 |
1706 | LGALS4, CEACAM6, TSPAN8, and COL1A2 | Colon, Rectum | Diagnosis | Rodia MT et al. Clin Colorectal Cancer. 2018 |
1707 | VEGF-D | Colon, Rectum | Prognosis | Carmeliet P et al. Ann Oncol. 2018 |
1708 | NKX6.1 hypermethylation | Colon, Rectum | Prognosis | Chang SY et al. Genes Chromosomes Cancer. 2018 |
1711 | Phosphoinositide-3-kinase regulatory subunit 3(PIK3R3) | Colon, Rectum | Prognosis, Treatment | Ibrahim S et al. Cancer Biol Ther. 2018 |
1712 | BEND5 | Colon, Rectum | Prognosis | Lin RK et al. Oncotarget. 2018 |
1713 | CTCF (CCCTC-binding factor)-binding sites | Colon, Rectum | Diagnosis | Liu J et al. Oncotarget. 2017 |
1714 | BCL-2-related ovarian killer (BOK) | Colon, Rectum | Prognosis | Carberry S et al. Cell Death Dis. 2018 |
1715 | transglutaminase 2 (TGM2) | Colon, Rectum | Prognosis | Kang S et al. Anticancer Res. 2018 |
1716 | carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Peltonen R et al. Tumour Biol. 2018 |
1718 | WDR54 | Colon, Rectum | Prognosis, Treatment | Yuan Y et al. Int J Cancer. 2019 |
1720 | kinesin family member 15, N‐acetyltransferase 2, glutathioneperoxidase 3, secretogranin II, and chloride channel accessory 1 | Colon, Rectum | Prognosis | Sun G et al. J Cell Physiol. 2019 |
1721 | exosomal Copine III (CPNE3) | Colon, Rectum | Diagnosis, Prognosis | Sun B et al. J Cell Physiol. 2019 |
1722 | protocadherin gamma-A7 (PCDHGA7) | Colon, Rectum | Prognosis | Liu Y et al. Hum Pathol. 2019 |
1729 | MMP14 | Colon, Rectum | Prognosis | Cui G et al. Hum Pathol. 2019 |
1732 | Chemokine (C-X-C motif) ligand 1 (CXCL1) | Colon, Rectum | Prognosis, Treatment | Zhuo C et al. Biosci Rep. 2018 |
1735 | zinc-alpha2-glycoprotein (ZAG) | Colon, Rectum | Diagnosis | Zhu H et al. Front Endocrinol (Lausanne). 2018 |
1736 | BACH1 | Colon, Rectum | Prognosis | Zhu GD et al. Biochem Biophys Res Commun. 2018 |
1737 | p16 protein | Colon, Rectum | Diagnosis, Prognosis | Zhou N et al. Medicine (Baltimore). 2018 |
1738 | DJ-1 | Colon, Rectum | Prognosis | Zhou J et al. Cell Death Dis. 2018 |
1739 | transgelin/TNS1 | Colon, Rectum | Prognosis, Treatment | Zhou H et al. Oncotarget. 2017 |
1742 | Leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5) | Colon, Rectum | Prognosis | Zheng Z et al. Oncotarget. 2018 |
1743 | GADD45B | Colon, Rectum | Prognosis | Zhao Z et al. Genes (Basel). 2018 |
1744 | stress-induced phosphoprotein 1 (STIP1) | Colon, Rectum | Prognosis | Zhang Z et al. Hum Pathol. 2018 |
1747 | Special AT-rich sequence-binding protein 2(SATB2 ) | Colon, Rectum | Diagnosis | Zhang YJ et al. EBioMedicine. 2018 |
1750 | clinical significance of B7 homolog 3 (B7-H3), beta-1, 3-galactosyltransferase-4 (B3GALT4) | Colon, Rectum | Prognosis | Zhang T et al. World J Gastroenterol. 2018 |
1752 | rhomboid domain containing 1 (RHBDD1) | Colon, Rectum | Prognosis, Treatment | Zhang M et al. J Exp Clin Cancer Res. 2018 |
1755 | leucinerich repeatcontaining 8A (LRRC8A) | Colon, Rectum | Prognosis | Zhang H et al. Oncol Rep. 2018 |
1760 | gamma coactivator-1alpha(PGC-1alpha) | Colon, Rectum | Prognosis | Yun SH et al. Ann Diagn Pathol. 2018 |
1762 | annexin A9 (ANXA9) | Colon, Rectum | Prognosis | Yu S et al. Int J Mol Med. 2018 |
1763 | Kininogen 1 (KNG1) | Colon, Rectum | Diagnosis | Yu J et al. J Cancer. 2018 |
1764 | Eukaryotic translation initiation factor 3, subunit H (EIF3H) | Colon, Rectum | Diagnosis | Yu G et al. Biosci Biotechnol Biochem. 2018 |
1765 | Prokineticin 2 (PROK2) | Colon, Rectum | Prognosis | Yoshida Y et al. Oncotarget. 2018 |
1766 | Serine/threonine kinase 33 (STK33) | Colon, Rectum | Diagnosis, Prognosis | Yin MD et al. Oncol Lett. 2018 |
1769 | Tenascin-C (TNC) | Colon, Rectum | Prognosis | Yang Z et al. Exp Mol Pathol. 2018 |
1772 | aldehyde dehydrogenase 1A1 (ALDH1A1) | Colon, Rectum | Prognosis | Yang W et al. Med Sci Monit. 2018 |
1773 | CD33(+) MDSCs, YAP1 and PTEN | Colon, Rectum | Prognosis | Yang R et al. Immunology. 2018 |
1775 | transcription factor AP4 (TFAP4) | Colon, Rectum | Prognosis | Yang J et al. Oncol Lett. 2018 |
1776 | Damage-specific DNA binding protein 2 (DDB2) | Colon, Rectum | Diagnosis, Prognosis | Yang H et al. Dig Dis Sci. 2018 |
1777 | Special AT-rich sequence-binding protein 2 (SATB2) | Colon, Rectum | Prognosis | Yang C et al. Gastroenterology Res. 2018 |
1778 | Nuclear division cycle 80 (NDC80) | Colon, Rectum | Diagnosis, Prognosis | Yan X et al. Cancer Med. 2018 |
1780 | pre- and postoperative C-reactive protein (CRP) | Colon, Rectum | Prognosis | Yamamoto M et al. Surg Today. 2018 |
1781 | Sialyl Lewis(x) (SLX) | Colon, Rectum | Prognosis | Yamadera M et al. Oncol Lett. 2018 |
1782 | HES6 | Colon, Rectum | Prognosis | Xu Y et al. Oncol Rep. 2018 |
1784 | chromodomain helicase DNA-binding proteins (CHDs)/CHD 9 | Colon, Rectum | Prognosis, Treatment | Xu L et al. Braz J Med Biol Res. 2018 |
1785 | carboxyl terminus of Hsc70-interacting protein (CHIP) | Colon, Rectum | Prognosis | Xu J et al. J Transl Med. 2018 |
1786 | C-X-C chemokine receptor type 4 (CXCR4) | Colon, Rectum | Prognosis | Xu C et al. Life Sci. 2018 |
1787 | Ubiquitin-specific peptidase 39 (USP39) | Colon, Rectum | Treatment | Xing Z et al. Oncol Lett. 2018 |
1788 | polo-like kinase 2 (Plk2) | Colon, Rectum | Prognosis, Treatment | Xie Y et al. Int J Oncol. 2018 |
1790 | Methylated Septin9 (mSEPT9) | Colon, Rectum | Diagnosis | Xie L et al. Front Oncol. 2018 |
1791 | Nucleobindin 2 (NUCB2) | Colon, Rectum | Prognosis | Xie J et al. Oncol Lett. 2018 |
1797 | IDH1 and B7H3 | Colon, Rectum | Prognosis | Wu J et al. Eur J Surg Oncol. 2018 |
1799 | Leukemia inhibitory factor receptor (LIFR) | Colon, Rectum | Prognosis, Treatment | Wu HX et al. Biochim Biophys Acta Mol Basis Dis. 2018 |
1800 | NOTCH4 | Colon, Rectum | Prognosis | Wu G et al. J Cancer. 2018 |
1801 | mRNA-decapping enzyme 1a (DCP1a) | Colon, Rectum | Diagnosis, Prognosis | Wu C et al. Oncol Lett. 2018 |
1803 | p70 ribosomal protein S6 kinase beta-1 (p70S6K) | Colon, Rectum | Prognosis | Wiesweg M et al. Clin Colorectal Cancer. 2018 |
1804 | serum amyloid A (SAA) | Colon, Rectum | Prognosis | Wierdak M et al. Surg Infect (Larchmt). 2018 |
1806 | osteopontin (OPN) | Colon, Rectum | Prognosis | Wei R et al. J Cell Mol Med. 2018 |
1808 | Fibulin-1 (FBLN1), serine threonine kinase-31 (STK31) | Colon, Rectum | Prognosis | Watany MM et al. Clin Chim Acta. 2018 |
1809 | Rab1A | Colon, Rectum | Diagnosis, Prognosis | Wang ZK et al. Eur Rev Med Pharmacol Sci. 2018 |
1811 | Syntaxin2 (STX2) | Colon, Rectum | Prognosis, Treatment | Wang Y et al. Cell Death Dis. 2018 |
1812 | ZNF331 | Colon, Rectum | Prognosis | Wang Y et al. Clin Epigenetics. 2018 |
1817 | REGgamma | Colon, Rectum | Prognosis | Wang Q et al. Clin Cancer Res. 2018 |
1820 | B-cell lymphoma 2 (Bcl-2) | Colon, Rectum | Prognosis | Wang J et al. Oncol Lett. 2018 |
1821 | tripartite motif 31(TRIM31) | Colon, Rectum | Diagnosis, Treatment | Wang H et al. Am J Transl Res. 2018 |
1822 | leucinerich repeatcontaining Gprotein coupled receptor 6 (Lgr6) | Colon, Rectum | Diagnosis, Prognosis | Wang Fe et al. Int J Mol Med. 2018 |
1824 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1(PLOD1) | Colon, Rectum | Prognosis, Treatment | Wang D et al. Genet Test Mol Biomarkers. 2018 |
1827 | GDF-15 | Colon, Rectum | Prognosis | Vocka M et al. Cancer Biomark. 2018 |
1828 | ZNF331 | Colon, Rectum | Prognosis | Vedeld HM et al. Clin Epigenetics. 2018 |
1834 | TNF-related, apoptosis-inducing ligand (TRAIL) | Colon, Rectum | Prognosis | Tsikalakis S et al. Pathol Res Pract. 2018 |
1836 | capping actin protein (CapG) | Colon, Rectum | Diagnosis, Prognosis | Tsai TJ et al. Anal Cell Pathol (Amst). 2018 |
1837 | caudal type homeobox 2 (CDX2) | Colon, Rectum | Diagnosis | Tóth C et al. Oncol Lett. 2018 |
1840 | IL-2 | Colon, Rectum | Prognosis | Taylor ES et al. Int J Cancer. 2018 |
1842 | AKAP4 and SPAG9 genes | Colon, Rectum | Diagnosis | Tavakoli Koudehi A et al. Asian Pac J Cancer Prev. 2018 |
1844 | G protein-coupled receptor kinase 6 (GRK6) | Colon, Rectum | Prognosis | Tao R et al. Oncol Lett. 2018 |
1846 | cancerous inhibitor of protein phosphatase 2A(CIP2A) | Colon, Rectum | Prognosis | Tang M et al. PLoS One. 2018 |
1847 | DDX1 | Colon, Rectum | Prognosis | Tanaka K et al. Cancer Sci. 2018 |
1848 | thymidylate synthase (TS) | Colon, Rectum | Prognosis | Takeyama H et al. Mol Clin Oncol. 2018 |
1849 | Pleomorphic adenoma gene like-2 (PLAGL2) | Colon, Rectum | Prognosis | Su C et al. Int J Oncol. 2018 |
1851 | Adenosine-to-inosine (A-to-I) RNA editing (AZIN1) | Colon, Rectum | Prognosis | Shigeyasu K et al. JCI Insight. 2018 |
1853 | Thyroid hormone Receptor Interactor 13 (TRIP13) | Colon, Rectum | Prognosis | Sheng N et al. Cell Death Dis. 2018 |
1856 | PITX2 | Colon, Rectum | Prognosis | Semaan A et al. Clin Colorectal Cancer. 2018 |
1859 | Lgr5 and CD133 | Colon, Rectum | Prognosis | Rosiq S et al. Open Access Maced J Med Sci. 2018 |
1860 | Annexin A2 (ANXA2) | Colon, Rectum | Prognosis | Rocha MR et al. Sci Rep. 2018 |
1863 | CD10 | Colon, Rectum | Prognosis, Treatment | Raposo TP et al. Exp Mol Pathol. 2018 |
1865 | ITGBL1 | Colon, Rectum | Prognosis, Treatment | Qiu X et al. Biomed Pharmacother. 2018 |
1868 | CNPY2 isoform 2 | Colon, Rectum | Diagnosis | Peng J et al. Aging (Albany NY). 2018 |
1870 | carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Peltonen R et al. Tumour Biol. 2018 |
1871 | AP-F13A1 | Colon, Rectum | Diagnosis | Peltier J et al. Clin Proteomics. 2018 |
1873 | DMBT1 | Colon, Rectum | Diagnosis, Prognosis | Park HS et al. Oncol Rep. 2018 |
1874 | TM4SF5 | Colon, Rectum | Prognosis | Park BK et al. Int J Oncol. 2018 |
1877 | granulin epithelin precursor (GEP) | Colon, Rectum | Prognosis, Treatment | Pan Y et al. J Transl Med. 2018 |
1878 | PRMT6 | Colon, Rectum | Diagnosis | Pan R et al. J Clin Lab Anal. 2018 |
1880 | fucosyltransferase 8(FUT8) | Colon, Rectum | Prognosis | Noda M et al. PLoS One. 2018 |
1881 | receptor superfamily member 19 (TROY) | Colon, Rectum | Prognosis | Nishioka M et al. Oncol Lett. 2018 |
1882 | histone deacetylases (HDACs)/ HDAC3 | Colon, Rectum | Prognosis | Nemati M et al. Adv Clin Exp Med. 2018 |
1883 | umbelliprenin | Colon, Rectum | Treatment | Naderi Alizadeh M et al. Iran J Pharm Res. 2018 |
1885 | FBXO39, ETS-1 | Colon, Rectum | Prognosis | Motalebzadeh J et al. Asian Pac J Cancer Prev. 2018 |
1886 | doublecortin and CaM kinase-like-1 protein (DCLK1) | Colon, Rectum | Prognosis | Morio K et al. Biomed Rep. 2018 |
1889 | doublecortin-like kinase 1 (DCLK1) | Colon, Rectum | Prognosis | Mohammadi Y et al. Biomed Pharmacother. 2018 |
1890 | mothers against decapentaplegic homolog 4 (SMAD4) | Colon, Rectum | Prognosis | Mizuno T et al. Eur J Surg Oncol. 2018 |
1891 | POU domain, class 5, transcription factor 1(POU5F1) | Colon, Rectum | Prognosis | Miyoshi N et al. Surg Today. 2018 |
1892 | dedicator of cytokinesis 2 (DOCK2) | Colon, Rectum | Prognosis, Treatment | Miao S et al. J Cell Biochem. 2018 |
1893 | vascular endothelial growth factor-C (VEGF-C) | Rectum | Prognosis | Miao H et al. J BUON. 2018 |
1896 | zymogen granule protein 16 (ZG16) | Colon, Rectum | Diagnosis, Prognosis | Meng H et al. BMC Cancer. 2018 |
1897 | indoleamine 2, 3-dioxygenase (IDO) | Colon, Rectum | Prognosis | Meireson A et al. Oncotarget. 2018 |
1898 | DEK | Rectum | Treatment | Martinez-Useros J et al. BMC Cancer. 2018 |
1900 | CDw75 epitope | Colon, Rectum | Prognosis | Mariño-Crespo Ó et al. Oncol Lett. 2018 |
1903 | cytoplasmic IDO1/COX2 | Colon, Rectum | Prognosis | Ma WJ et al. World J Gastroenterol. 2018 |
1905 | special AT-rich sequence binding protein (SATB2) | Colon, Rectum | Prognosis | Ma C et al. Am J Surg Pathol. 2018 |
1906 | B cell-associated protein 31 (BAP31) | Colon, Rectum | Prognosis | Ma C et al. Pathol Res Pract. 2018 |
1909 | soluble urokinase plasminogen activator receptor (suPAR) | Colon, Rectum | Prognosis | Loosen SH et al. Oncotarget. 2018 |
1910 | SM22alpha | Colon, Rectum | Diagnosis, Prognosis | Liu Y et al. Oncol Lett. 2018 |
1915 | collagen type VI alpha3 chain (COL6A3) | Colon, Rectum | Prognosis, Treatment | Liu W et al. Oncol Rep. 2018 |
1918 | PD-L1 expression and RAS status | Colon, Rectum | Prognosis | Liu R et al. Biomed Res Int. 2018 |
1920 | tripartite motif protein (TRIM) family/ TRIM58 | Colon, Rectum | Prognosis | Liu M et al. Oncol Rep. 2018 |
1921 | solute carrier family 34 member 2 (SLC34A2) | Colon, Rectum | Diagnosis, Treatment | Liu L et al. Biomed Pharmacother. 2018 |
1922 | ras-related protein 1A (RAP1A) | Colon, Rectum | Treatment | Liu L et al. J Exp Clin Cancer Res. 2018 |
1923 | forkhead box C1 (FOXC1) | Colon, Rectum | Prognosis | Liu J et al. Oncogene. 2018 |
1924 | H3K4me3, Wdr82 | Colon, Rectum | Prognosis | Liu H et al. Oncol Lett. 2018 |
1927 | DJ-1 | Colon, Rectum | Prognosis, Treatment | Lin Y et al. Cancer Med. 2018 |
1928 | KIF20B | Colon, Rectum | Treatment | Lin WF et al. Mol Carcinog. 2018 |
1929 | PRMT6 | Colon | Diagnosis, Treatment | Lim Y et al. Oncotarget. 2017 |
1930 | metalloproteinase-9 (MMP-9) | Colon, Rectum | Diagnosis | Liang S et al. Biomark Med. 2018 |
1935 | MUC2 | Colon, Rectum | Prognosis | Li C et al. Gastroenterol Res Pract. 2018 |
1938 | CD274, LAG3, and IDO1 | Colon | Prognosis, Treatment | Lee SJ et al. J Cancer Res Clin Oncol. 2018 |
1939 | PBX3 | Colon, Rectum | Prognosis, Treatment | Lamprecht S et al. Clin Cancer Res. 2018 |
1940 | CREPT | Colon, Rectum | Prognosis | Kuang YS et al. World J Gastroenterol. 2018 |
1941 | ALDH1A | Colon | Prognosis | Kozovska Z et al. BMC Cancer. 2018 |
1944 | MCT4 | Colon, Rectum | Prognosis, Treatment | Kim HK et al. Mol Cancer Ther. 2018 |
1946 | HSP90 | Colon, Rectum | Diagnosis | Kasanga M et al. Biomark Med. 2018 |
1947 | VEGFR2 | Colon, Rectum | Prognosis | Kanekiyo S et al. Oncol Rep. 2018 |
1948 | Gal-3 | Colon, Rectum | Prognosis | Jovanovic M et al. Mediators Inflamm. 2018 |
1950 | Spy1 | Colon, Rectum | Diagnosis, Prognosis | Jin Q et al. Cancer Manag Res. 2018 |
1952 | PinX1 | Colon, Rectum | Prognosis | Jiang T et al. Oncol Rep. 2018 |
1953 | Cystatin SN (cystatin 1, CST1) | Colon, Rectum | Prognosis | Jiang J et al. Int J Oncol. 2018 |
1957 | leucine-rich, repeat-containing, G-protein-coupled receptor 5 (LGR5) | Colon, Rectum | Prognosis | Jang BG et al. Am J Pathol. 2018 |
1958 | EPHB2 | Colon, Rectum | Prognosis | Jang BG et al. J Pathol Transl Med. 2018 |
1959 | ATF3 | Colon, Rectum | Prognosis | Inoue M et al. PLoS One. 2018 |
1960 | Aquaporin 1 (AQP1) | Colon, Rectum | Prognosis | Imaizumi H et al. Oncol Lett. 2018 |
1962 | phosphoinositide-3-kinase regulatory subunit 3(PIK3R3) | Colon, Rectum | Prognosis, Treatment | Ibrahim S et al. Cancer Biol Ther. 2018 |
1963 | CD133 | Colon, Rectum | Prognosis, Treatment | Huang R et al. Medicine (Baltimore). 2018 |
1964 | ITGAE | Colon, Rectum | Prognosis | Hu X et al. EBioMedicine. 2018 |
1965 | Wnt/beta-catenin signaling, Wnt inhibitory factor 1 (WIF1) | Colon, Rectum | Prognosis | Hu H et al. Oncotarget. 2018 |
1967 | kinesin family member 4A (KIF4A) | Colon, Rectum | Prognosis | Hou PF et al. Cell Death Dis. 2018 |
1968 | jumonji domain-containing 4 (JMJD4) | Colon | Prognosis | Ho YJ et al. Biochem Biophys Res Commun. 2018 |
1969 | A-kinase anchor protein 12 (AKAP12) | Colon, Rectum | Prognosis, Treatment | He P et al. Int J Oncol. 2018 |
1970 | activin receptor like-protein 1 (ACVRL1) | Colon, Rectum | Prognosis | Hanna DL et al. Clin Colorectal Cancer. 2018 |
1971 | transcription factor forkhead box D1 (FOXD1) | Colon, Rectum | Prognosis | Han T et al. Biomed Pharmacother. 2018 |
1972 | nudC domain containing 1 (NUDCD1) | Colon, Rectum | Prognosis | Han B et al. Am J Cancer Res. 2018 |
1973 | pre-operative carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Gunawardene A et al. ANZ J Surg. 2018 |
1975 | VWA2 | Colon, Rectum | Prognosis | González B et al. Sci Rep. 2018 |
1976 | carcinoembryonic antigen (CEA) | Colon, Rectum | Diagnosis, Prognosis, Treatment | Gao Y et al. Sci Rep. 2018 |
1980 | tumor necrosis factor receptor-associated protein-1 (TRAP-1) | Colon, Rectum | Prognosis | Gao C et al. Oncol Lett. 2018 |
1982 | chitinase-3-like protein 1 (YKL-40) | Colon, Rectum | Prognosis | Fuksiewicz M et al. Technol Cancer Res Treat. 2018 |
1983 | Mina53 | Colon, Rectum | Prognosis | Fujino S et al. Oncol Rep. 2018 |
1985 | mSEPT9 | Colon, Rectum | Prognosis | Fu B et al. Dis Markers. 2018 |
1988 | XPA | Colon, Rectum | Prognosis | Feng X et al. Cancer Med. 2018 |
1993 | Cystatin S (CST4) | Colon, Rectum | Diagnosis | Dou Y et al. Onco Targets Ther. 2018 |
1995 | dual-specificity phosphatase-2 (DUSP2) | Colon, Rectum | Prognosis, Treatment | Dong W et al. Oncol Lett. 2018 |
1996 | periostin (POSTN) | Colon, Rectum | Diagnosis, Prognosis | Dong D et al. Clin Lab. 2018 |
1997 | centromere protein I (CENPI) | Colon, Rectum | Prognosis | Ding N et al. Gene. 2018 |
1999 | cyclophilin B(CypB) | Colon, Rectum | Prognosis | Choi TG et al. J Pathol. 2018 |
2000 | EZH2 | Colon, Rectum | Prognosis | Chen Z et al. Oncol Lett. 2018 |
2006 | ADAMTS4 | Colon, Rectum | Prognosis | Chen J et al. Cell Physiol Biochem. 2018 |
2009 | NKX6.1 | Colon, Rectum | Prognosis | Chang SY et al. Genes Chromosomes Cancer. 2018 |
2010 | nestin | Colon, Rectum | Prognosis | Chabowski M et al. Anticancer Res. 2018 |
2012 | BOK | Colon, Rectum | Prognosis | Carberry S et al. Cell Death Dis. 2018 |
2014 | low-density lipoprotein receptor-related protein 1 (LRP1) | Colon | Prognosis | Boulagnon-Rombi C et al. Oncotarget. 2018 |
2015 | 92 analyzed plasma proteins, osteoprotegerin | Colon, Rectum | Prognosis | Birgisson H et al. Transl Oncol. 2018 |
2020 | nucleoside diphosphate kinase A (NDKA) | Colon, Rectum | Prognosis | Álvarez-Chaver P et al. Methods Mol Biol. 2018 |
2021 | SSH1 | Colon, Rectum | Prognosis, Treatment | Aggelou H et al. Virchows Arch. 2018 |
2024 | phosphoserine aminotransferase 1 (PSAT1) | Colon, Rectum | Prognosis, Treatment | Qian C et al. Oncol Lett. 2017 |
2027 | CST1 | Colon, Rectum | Prognosis | Li T et al. Oncotarget. 2017 |
2028 | HSF-1 | Colon, Rectum | Prognosis | Bhardwaj M et al. Oncotarget. 2017 |
2030 | Receptor Tyrosine Kinase EphB3 | Colon, Rectum | Prognosis | Xuan, Z et al. Pathol Oncol Res. 2020 |
2033 | Lgr5 | Colon, Rectum | Diagnosis, Prognosis | Salehzadeh, S et al. J Gastrointest Cancer. 2020 |
2035 | Wnt target gene(AXIN2, NKD1) | Colon, Rectum | Prognosis | Kleeman, S. O et al. Gut. 2020 |
2037 | HSPB3 | Colon, Rectum | Prognosis | Kalioraki, M. A et al. Mol Carcinog. 2020 |
2039 | HLA‑G | Colon, Rectum | Diagnosis | Lázaro-Sánchez, A. D et al. Clin Transl Oncol. 2020 |
2040 | KRT17 | Colon, Rectum | Prognosis | Ujiie, D et al. Carcinogenesis. 2020 |
2045 | BMP‑9 | Colon, Rectum | Prognosis | Fan, Y et al. Oncol Lett. 2020 |
2046 | Clusterin (CLU) | Colon, Rectum | Prognosis | Engel, R. M et al. J Clin Med. 2020 |
2049 | Serum Midkine | Colon, Rectum | Prognosis | Kemper, M et al. Cancer Med. 2020 |
2051 | HBXIP | Colon, Rectum | Prognosis | Wang, X et al. Life Sci. 2020 |
2053 | GINS4 | Colon, Rectum | Prognosis | Rong, Z et al. Cancer Sci. 2020 |
2057 | CEACAM5 + KLK6 + SLC35D3 + MUC2 + POSTN | Colon, Rectum | Prognosis | Olsson, L et al. PLoS One. 2020 |
2059 | KARS1 | Colon, Rectum | Diagnosis, Prognosis | Suh, J. H et al. J Clin Med. 2020 |
2060 | FGFRL1 | Rectum | Prognosis | Jia, R. Z et al. J Recept Signal Transduct Res. 2020 |
2061 | TEM1 | Colon, Rectum | Diagnosis, Prognosis | Pietrzyk, Ł and Wdowiak, P et al. Cancer Control. 2020 |
2062 | CDX2 | Colon, Rectum | Prognosis | Aasebø, K et al. Front Oncol. 2020 |
2064 | VDR | Colon, Rectum | Diagnosis | Al-Ghafari, A. B et al. Saudi J Biol Sci. 2020 |
2065 | ADAMTS4 | Colon, Rectum | Prognosis | Shang, X. Q et al. Rev Assoc Med Bras (1992). 2020 |
2068 | 12-Chemokine | Colon, Rectum | Prognosis | Tokunaga, R et al. Int J Cancer. 2020 |
2069 | IRF1 | Colon, Rectum | Diagnosis | Wu, Y et al. Oncol Lett. 2020 |
2072 | P2X7 receptor | Colon, Rectum | Prognosis | Calik, I et al. Int J Clin Exp Pathol. 2020 |
2073 | CD26 | Colon, Rectum | Diagnosis | Elzefzafy, W. M et al. J Immunoassay Immunochem. 2020 |
2075 | STAT1 | Colon, Rectum | Prognosis | Tanaka, A et al. PLoS One. 2020 |
2076 | LOX‑1 | Colon, Rectum | Prognosis | Nakashima-Nakasuga, C et al. Int J Clin Oncol. 2020 |
2078 | MICB | Colon, Rectum | Prognosis | Feng, Q et al. J Cancer Res Clin Oncol. 2020 |
2081 | PAI1 | Rectum | Prognosis | Muñoz-Galván, S et al. Cells. 2020 |
2089 | Homer1 | Colon, Rectum | Prognosis | Cui, X et al. Cancer Manag Res. 2020 |
2092 | netrin-1 | Colon, Rectum | Diagnosis | Li, B et al. Cancer Biomark. 2020 |
2097 | SYPL1 | Colon, Rectum | Diagnosis | Liu, L et al. Clin Chim Acta. 2020 |
2099 | E-cadherin | Colon, Rectum | Diagnosis | Zhu, S et al. Gene. 2020 |
2105 | Maspin | Colon, Rectum | Prognosis | Tanaka, A et al. Front Oncol. 2020 |
2108 | SIRT1 | Colon, Rectum | Prognosis | Lee, G. J et al. Korean J Intern Med. 2021 |
2110 | DUSP4 | Colon, Rectum | Diagnosis | Varela, T et al. Biomark Med. 2020 |
2114 | DJ‑1 | Colon, Rectum | Prognosis | Wang, W et al. Oncol Rep. 2020 |
2115 | TNNT2 | Colon, Rectum | Prognosis | Jing, L et al. Oncol Rep. 2020 |
2116 | ZW10 | Colon, Rectum | Diagnosis, Prognosis | Dang, Y et al. Clin Transl Med. 2020 |
2117 | ASCL2 | Colon, Rectum | Prognosis | Walker, B. S et al. World J Surg. 2020 |
2124 | PKM2 | Colon, Rectum | Treatment | Sfakianaki, M et al. Cancers (Basel). 2020 |
2127 | DPP9 | Colon, Rectum | Prognosis | Saso, K et al. Ann Surg Oncol. 2020 |
2130 | CD133 | Colon, Rectum | Diagnosis | Kostovski, O et al. Pol Przegl Chir. 2020 |
2131 | γ‑H2AX | Colon, Rectum | Prognosis | Kawashima, S et al. Oncol Lett. 2020 |
2132 | ABC transporters | Colon, Rectum | Diagnosis | Qutub, R. M et al. Saudi Med J. 2020 |
2137 | AXL | Colon, Rectum | Prognosis | Cardone, C et al. Eur J Cancer. 2020 |
2138 | CD163 | Colon, Rectum | Prognosis | Krijgsman, D et al. Int J Mol Sci. 2020 |
2140 | NAP1L1 | Colon, Rectum | Prognosis | Queiroz, C. J. S et al. Front Oncol. 2020 |
2141 | DEFB4A | Colon, Rectum | Prognosis | Wu, Q et al. Oncol Lett. 2020 |
2144 | NRF2 | Colon, Rectum | Prognosis | O'Cathail, S. M et al. Cancer Genet. 2020 |
2149 | IL-8 | Colon, Rectum | Prognosis | Suenaga, M et al. Int J Colorectal Dis. 2021 |
2156 | DCLK1 | Colon, Rectum | Diagnosis, Treatment | Razi, S et al. Clin Exp Med. 2021 |
2158 | M2-Pyruvate Kinase | Colon, Rectum | Diagnosis | Che Alhadi, S et al. Ann Coloproctol. 2020 |
2166 | NEO1 | Colon, Rectum | Prognosis | Zhang, M et al. Cancer Cell Int. 2020 |
2169 | HOXA5 | Colon, Rectum | Prognosis | Yaiche, H et al. Cancer Biomark. 2021 |
2173 | TGF-β2 | Colon, Rectum | Prognosis | Tu, Y et al. Medicine (Baltimore). 2020 |
2176 | IL-10 | Colon, Rectum | Prognosis | Chang, J et al. Onco Targets Ther. 2020 |
2177 | GJA1 | Colon, Rectum | Prognosis | Hu, W et al. Cancer Manag Res. 2020 |
2178 | Siglec-7 | Colon, Rectum | Prognosis | Yamada, K et al. Oncol Lett. 2021 |
2186 | p62 | Rectum | Prognosis | Kobayashi, T et al. Colorectal Dis. 2021 |
2188 | DDX21 | Colon, Rectum | Prognosis | Tanaka, A et al. Sci Rep. 2020 |
2191 | ELF3 | Colon, Rectum | Prognosis | Takaoka, A et al. In Vivo. 2021 |
2192 | MYC | Colon, Rectum | Prognosis | Kato, T et al. In Vivo. 2021 |
2203 | ANXA1 | Colon, Rectum | Diagnosis, Prognosis | Liang, Z. and Li, X et al. Autoimmunity. 2021 |
2204 | IL‑2Ra and IL‑8 | Colon, Rectum | Prognosis | Björkman, K et al. Sci Rep. 2021 |
2205 | TEAD4 with SIX1 | Colon, Rectum | Prognosis | Yu, T et al. Cancer Manag Res. 2021 |
2207 | CXCL7 | Colon, Rectum | Diagnosis, Prognosis | Li, L et al. Front Oncol. 2020 |
2208 | HIPK2 | Colon, Rectum | Prognosis | Verdina, A et al. Oncol Rep. 2021 |
2211 | REG4 | Colon, Rectum | Prognosis | Gao, L et al. Onco Targets Ther. 2021 |
2214 | AMIGO2 | Colon, Rectum | Prognosis | Tanio, A et al. Oncol Lett. 2021 |
2215 | TMEM180 | Colon, Rectum | Prognosis | Shiraishi, T et al. BMC Cancer. 2021 |
2217 | CCL2 | Colon, Rectum | Prognosis | Fukunaga, M et al. Surg Today. 2021 |
2218 | QSOX1 | Colon, Rectum | Diagnosis | Ganig, N et al. Cancers (Basel). 2021 |
2220 | CMTM6 | Colon, Rectum | Prognosis | Wu, X et al. Cancer Immunol Immunother. 2021 |
2225 | TEM8 | Colon, Rectum | Diagnosis, Prognosis | Pietrzyk, Ł, Korolczuk, A et al. Cancer Manag Res. 2021 |
2226 | AVL9 | Colon, Rectum | Diagnosis, Prognosis | Li, D et al. Cancer Manag Res. 2021 |
2227 | Transferrin | Colon, Rectum | Prognosis | Sawayama, H et al. Ann Gastroenterol Surg. 2021 |
2231 | IL10 | Colon, Rectum | Prognosis | Jeong, S. Y et al. Sci Rep. 2021 |
2237 | CA125 | Colon, Rectum | Prognosis | Björkman, K et al. Tumour Biol. 2021 |
2238 | c- Met | Colon, Rectum | Prognosis | Armstrong, G. R et al. Int J Exp Pathol. 2021 |
2244 | IBSP | Colon, Rectum | Diagnosis, Prognosis, Treatment | Chen, Y et al. Cancer Med. 2021 |
2246 | CALD1 | Colon, Rectum | Prognosis | Zheng, H et al. Front Mol Biosci. 2021 |
2250 | GP73 | Colon, Rectum | Diagnosis | Abdelhady, S. A et al. Cancer Rep (Hoboken). 2021 |
2252 | CCT6A | Colon, Rectum | Prognosis | Sun, H et al. Front Genet. 2021 |
2257 | Claudin-2 | Colon, Rectum | Prognosis | Tabariès, S et al. Commun Biol. 2021 |
2266 | APOC1 | Colon, Rectum | Diagnosis, Prognosis | Shen, H. Y et al. World J Clin Cases. 2021 |
2267 | HER2 | Colon, Rectum | Prognosis | Huang, W et al. J Cancer Res Clin Oncol. 2022 |
2269 | CDX-2 | Colon, Rectum | Prognosis | Korphaisarn, K et al. Asia Pac J Clin Oncol. 2022 |
2270 | ZNF26 | Colon, Rectum | Diagnosis, Prognosis | Liu, J et al. Front Cell Dev Biol. 2021 |
2272 | IGF2BP1 | Colon, Rectum | Prognosis | Chen, H. M et al. Int J Mol Sci. 2021 |
2273 | Granulin | Colon, Rectum | Prognosis | Klupp, F et al. Int J Mol Sci. 2021 |
2274 | SLC2A3 | Colon, Rectum | Prognosis | Gao, H et al. Front Oncol. 2021 |
2279 | TMEM236 | Colon, Rectum | Diagnosis | Maurya, N. S et al. Sci Rep. 2021 |
2281 | Nodal | Colon, Rectum | Prognosis | Wang, X et al. Pathol Oncol Res. 2021 |
2282 | MIC-1 | Colon, Rectum | Diagnosis | Dai, C et al. Biomarkers. 2021 |
2287 | MUC2 | Rectum | Prognosis | Chou, C. L et al. J Clin Med. 2021 |
2289 | HER2 | Colon, Rectum | Diagnosis, Prognosis | Abdul Razzaq, E. A et al. Libyan J Med. 2021 |
2290 | FSTL3 | Colon, Rectum | Prognosis | Yang, C et al. Front Immunol. 2021 |
2291 | CST2 | Colon, Rectum | Diagnosis, Prognosis | Xie, Q et al. J Cancer. 2021 |
2292 | SIGLEC5 | Colon, Rectum | Prognosis | Montalbán-Hernández, K et al. Cancers (Basel). 2021 |
2294 | Gankyrin | Colon, Rectum | Diagnosis | Wang, C et al. Front Oncol. 2021 |
2296 | CRP | Colon, Rectum | Prognosis | Fujikawa, H et al. J Anus Rectum Colon. 2021 |
2298 | ITGB4 | Colon, Rectum | Diagnosis | Jiang, X et al. Cancer Med. 2021 |
2299 | DJ-1 | Colon, Rectum | Prognosis | Chen, W. T et al. Cancers (Basel). 2021 |
2302 | CK7 | Colon, Rectum | Prognosis | Hrudka, J et al. Sci Rep. 2021 |
2307 | NUDT1 | Colon, Rectum | Prognosis | Bialkowski, K et al. Free Radic Biol Med. 2021 |
2309 | PLOD3 | Colon, Rectum | Diagnosis, Prognosis | Shi, J et al. Front Immunol. 2021 |
2311 | PROK1 | Colon, Rectum | Prognosis | Tagai, N et al. World J Surg Oncol. 2021 |
2313 | IL- 33 | Colon, Rectum | Prognosis, Treatment | Zhang, X et al. Cancer Med. 2021 |
2316 | MC1R | Colon, Rectum | Prognosis | Peng, L et al. Curr Issues Mol Biol. 2021 |
2317 | LATS2 | Colon, Rectum | Prognosis | Zhao, C et al. Bioengineered. 2021 |
2323 | PLK4 | Rectum | Prognosis | Oh, H et al. J Pathol Transl Med. 2022 |
2324 | ZNF677 | Colon, Rectum | Prognosis | Siraj, A. K et al. Sci Rep. 2021 |
2331 | ECAD | Colon, Rectum | Prognosis | Bruun, J et al. Mol Oncol. 2022 |
2332 | PZP | Colon, Rectum | Diagnosis | Yang, J et al. Front Mol Biosci. 2021 |
2335 | CXCL12 | Rectum | Prognosis | Kim, S et al. J Cancer. 2022 |
2339 | H3K27ac | Colon, Rectum | Treatment | Chen, Z. X et al. Dose Response. 2021 |
2343 | SMAD4-201 | Colon, Rectum | Diagnosis | Babic, T et al. BMC Cancer. 2022 |
2345 | HSP110 | Colon, Rectum | Diagnosis | Tachon, G et al. Front Genet. 2021 |
2346 | SCG2 | Colon, Rectum | Prognosis | Wang, H et al. Front Cell Dev Biol. 2021 |
2348 | METTL11B | Colon, Rectum | Prognosis, Treatment | Zhou, Y et al. J Gastrointest Oncol. 2021 |
2350 | SPARCL1 | Colon, Rectum | Prognosis | Zhang, H. P et al. Biomed Res Int. 2022 |
2352 | CFIm25 | Colon, Rectum | Prognosis | Cai, Y et al. Transl Cancer Res. 2021 |
2356 | CX3CR1 | Colon, Rectum | Prognosis | Yue, Y et al. Front Immunol. 2021 |
2357 | Mapk14 | Colon, Rectum | Prognosis | Wang, D et al. Front Cell Dev Biol. 2022 |
2358 | FATP5 | Colon, Rectum | Prognosis | Geng, Q. S et al. Front Mol Biosci. 2021 |
2359 | CRP | Rectum | Treatment | Aires, F et al. Cancers (Basel). 2022 |
2361 | SPDL1 | Colon, Rectum | Prognosis | Klimaszewska-Wiśniewska, A et al. Int J Mol Sci. 2022 |
2362 | NNMT | Colon, Rectum | Prognosis | Ogawa, M et al. Sci Rep. 2022 |
2364 | ANO1 | Colon, Rectum | Prognosis | Chen, J et al. Int J Gen Med. 2022 |
2366 | SYPL1 | Colon, Rectum | Diagnosis, Prognosis, Treatment | Shu, T et al. Clin Biochem. 2022 |
2370 | ARHGAP25 | Colon, Rectum | Prognosis | Zhang, Y et al. Mol Clin Oncol. 2022 |
2375 | RAI2 | Colon, Rectum | Prognosis | Zhang, W et al. Front Oncol. 2022 |
2378 | B3GNT6 | Colon, Rectum | Prognosis | Xiao, S et al. World J Surg Oncol. 2022 |
2380 | SLC2A1 | Colon, Rectum | Diagnosis | Liu, X. S et al. Front Cell Dev Biol. 2022 |
2388 | CYCS, IKBKB, NFKB1, TRADD | Rectum | Prognosis | Zhu, Q et al. Dis Markers. 2022 |
2389 | MT1G | Colon, Rectum | Prognosis | Peng, B et al. Front Cell Dev Biol. 2022 |
2390 | DIAPH3 | Colon, Rectum | Prognosis | Huang, R et al. Cancer Med. 2022 |
2396 | FOXD1 + Plk2 | Colon, Rectum | Prognosis | Zong, Y et al. J Cell Mol Med. 2022 |
2397 | S100P | Colon, Rectum | Prognosis | Schmid, F et al. Br J Cancer. 2022 |
2399 | CD10 | Colon, Rectum | Diagnosis | Żurawski, J et al. Gastroenterol Hepatol Bed Bench. 2022 |
2402 | CHGA | Colon, Rectum | Diagnosis | Zhang, X et al. Cancers (Basel). 2022 |
2403 | EphA2 | Colon, Rectum | Prognosis | Li, W et al. Biosens Bioelectron. 2022 |
2404 | CD133 | Colon, Rectum | Prognosis | Mersakova, S et al. Oncol Lett. 2022 |
2405 | LIMK1 | Colon, Rectum | Prognosis | Liu, X et al. Oncol Lett. 2022 |
2407 | P21 | Rectum | Prognosis | Kozłowska-Geller, M. A et al. Contemp Oncol (Pozn). 2020 |
2409 | C- reactive protein | Rectum | Prognosis | Hoek, V. T et al. Colorectal Dis. 2022 |
2416 | HMGB1 | Colon, Rectum | Prognosis | Sun, Y. D et al. Front Oncol. 2020 |
2417 | CD133 | Colon, Rectum | Prognosis | Czeczko, L. E. A et al. Arq Bras Cir Dig. 2021 |
2418 | suPAR | Colon, Rectum | Prognosis | Blomberg, K et al. Cancers (Basel). 2021 |
2419 | PLS3 | Colon, Rectum | Diagnosis | Born, J et al. Cancers (Basel). 2021 |
2421 | RASSF1A | Colon, Rectum | Prognosis | Hu, F et al. Pathol Res Pract. 2020 |
2426 | Claudin-1 | Colon, Rectum | Prognosis | Zuo, D et al. Gastroenterol Res Pract. 2020 |
2428 | CDX2 | Colon, Rectum | Diagnosis, Prognosis | Choi et al. Diagnostics (Basel). 2022 |
2430 | Vimentin | Colon, Rectum | Prognosis, Treatment | Du, L et al. Biomed Res Int. 2018 |
2438 | TIMP-1 | Colon, Rectum | Diagnosis | Meng, C et al. PLoS One. 2018 |
2439 | Metalloproteinase-9 (MMP-9) | Colon, Rectum | Diagnosis | Liang, S et al. Biomark Med. 2018 |